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“Everybody knows what stress is and nobody knows what it is. The 
word stress, like success, failure, or happiness, means different things 
to different people and, except for a few specialized scientists, no one 
has really tried to define it although it has become part of our daily 
vocabulary. It is effort, fatigue, pain, fear, the need for concentration, 
the humiliation of censure, loss of blood, or even an unexpected success 
that requires complete reformulation of one’s life? The answer is yes 
and no. That is what makes the definition of stress so difficult. Every 
one of these conditions can produce stress, and yet none of them can be 
sigled out as being “it” since the word applies equally to all others as 
well.” 
Hans Selye, 1973, American Scientist, p.692 
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ABSTRACT 
Stress physiology overlaps to a great extent in humans and mice, thus 
preclinical models can guide and refine hypothesis-driven clinical research 
questions. The brain is a primary mediator and target of stress resiliency and 
vulnerability because it determines what is threatening and regulates 
behavioural and physiological responses to a given stressor. A growing body of 
evidence suggests that the sustained activation of the HPA axis, and the 
consequent suppressed activity of the immune system mediated by 
glucocorticoid hormones, may increase the susceptibility to disease. The 
connection between central stress response pathways and peripheral targets 
involves a number of neurochemical and/or inflammatory factors that ultimately 
affect neuronal functioning and/or survival as well as adaptive physiological 
responses that allow fighting against external challenges. In this regard Brain-
Derived Neurotrophic Factor (BDNF) represents a crucial factor for the 
integration of neural, immune, endocrine and metabolic responses to stressful 
challenges. However, the quality and quantity of stress, and the mechanisms 
leading to increased susceptibility to disease, are still a matter of intense 
investigation. The general objective of the work presented in this thesis was to 
characterise how quality and timing of stressors differentially impact on 
behavioural, neuroendocrine and immune profile in animal models. To this aim 
both central (BDNF levels) and peripheral (CORT, cytokines, splenic apoptosis, 
leptin and adiponectin levels) responses, as well as endophenotype of 
depression, were analyzed in mouse models. In particular, in Chapter 2, we 
report about the impact of social deprivation on anxiety and depressive-like 
behaviours, promoting a disrupted emotional state, while in Chapter 3 we 
identify a specific neuroendocrine-immune profile associated to specific 
changes in central mediators, describing the relevance of the nature and length 
of stress exposure. Both these studies relied on the assessment of BDNF as the 
principal mediator in the orchestration of brain and peripheral responses. 
Chapter 4 describes research in which both psychophysical and social stressors 
promote disease in a transgenic mouse model of breast cancer, through a 
specific neuroendocrine-immune-leptin axis. Analyses of the effects of stressful 
events in wild type and transgenic mice – described in Chapter 2, 3 and 4 - 
highlight the importance of individual responses to environmental stimuli in 
defining the outcome of disease. Results are discussed considering that stressful 
life events are related to a range of physical and emotional health problems and 
reduced quality of life, social support being a crucial protective factor in disease 
susceptibility.  
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1. GENERAL INTRODUCTION 
 
1.1. STRESS IS A RISK FACTOR FOR PSYCHONEUROENDOCRINE 
REGULATIONS 
 
1.1.1. Stress definition - What is stress? 
Stress can be described as any change in the external or internal environment 
perturbing the homeostasis of an organism. Selye in 1936 described the "general 
adaptation syndrome" as a complex mechanism of activation of the 
neuroendocrine system to prepare the body to respond to external challenges. 
Stress begins in the brain with the perception and elaboration of an external 
event as stressful and affects the brain itself, as well as the rest of the body, 
through plastic changes, leading to adaptation (McEwen and Seeman, 1999). 
 Coping strategies, reflected in adaptive physiological changes, are 
therefore important components of the stress response. Thus, during stress, 
attention is enhanced and the brain focuses on the perceived threat, cardiac 
output and respiration are accelerated, catabolism is increased and blood flow is 
redirected to provide the highest perfusion and fuel to the aroused brain, heart 
and muscles to allow an animal to “fright, fight or flight” (Chrousos and Gold, 
1992). The connection between central stress response pathways and peripheral 
targets involves the activation of a number of neurochemical and/or 
inflammatory mediators that ultimately can affect cell function and/or survival 
including cytokines and growth factors (Hayley et al., 2005; Cirulli and Alleva, 
2009; Moreno-Smith et al., 2011; Capoccia et al., 2013).  
The perception of stress is influenced by experiences, genetic 
background and behaviour. It must be taken into account that there are 
significant individual differences in stress perception, processing, appraisal and 
coping, based upon the experience of the individual (Gunnar and Quevedo, 
2007; Dhabhar, 2008). Positive or negative experiences at school, work or in 
interpersonal relationships can prejudice an individual towards either a positive 
or negative response in a new situation. How the individual reacts may carry 
over into habits such as smoking, drinking excessively, eating too much, poor 
sleep, lack of exercise and interaction with friends and family, all of which 
contribute to allostatic overload (McEwen and Seeman, 1999).  
The consequences of stress responses are generally adaptive insofar as 
they extend for a short time, but can become very harmful when stress is 
chronic and prolonged (Munck et al., 1984; Dhabhar and McEwen, 1997; 
McEwen and Seeman, 1999). In this context, it is important to distinguish the 
duration and intensity of the stress. Acute stress lasts for a period ranging from 
minutes to hours, while chronic stress persists for days to months. Stress can be 
quantified by measuring the levels of stress hormones and neurotransmitters, as 
well as evaluating the extent of concurrent physiological changes, such as 
increased heart rate and blood pressure. In this regard, the central nervous 
system (CNS), the hypothalamic-pituitary-adrenal (HPA) axis and also the 
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immune system (IS) act leading to protection and adaptation of the organism to 
environmental challenges (allostasis) (Kort, 1994; Kiecolt-Glaser et al., 1996; 
Avitsur et al., 2009). However, chronic dysregulation (i.e., over-activity or 
inactivity) of these physiological systems promotes the persistent elevation of 
stress mediators and the consequent allostatic load (McEwen and Gianaros, 
2010). 
 
1.1.2. Stress effects on neuroendocrine function  
The neuroendocrine system is pivotal to the allostatic/adaptive responses to 
stress, employing neuropeptides and hormones as mediators. The HPA axis 
(which releases the glucocorticoids - GC - hormones) and sympathetic 
adrenomedullary systems (which releases catecholamines) coordinate the stress 
response in brain and periphery. They act as integrating units controlling the 
physiological and behavioural adaptive responses necessary for an organism to 
cope with stress (in a time-limited fashion) and their functioning is, in turn, 
affected by stress.  
An important signal for the deleterious effects of chronic stress is the 
disruption of the circadian rhythm of corticosterone in rodents (Dhabhar and 
McEwen, 1997) and the rhythm of cortisol in humans (Sephton et al., 2000). 
Under basal conditions the HPA axis coordinates daily and sleep related 
events through the secretion of corticotrophin-releasing hormone (CRH), 
adrenocorticotropic hormone (ACTH) and GC (Windle et al., 1998; Young et 
al., 2004). The amplitude of this ultradian adrenal GC rhythm is enhanced 
during the activity period (the dark phase in rodents). Amplitude and frequency 
can change during disease and the aging process (Lightman et al., 2008). 
Activation of the HPA axis, by either psychological or physiological threats, 
can occur at any time and results in the release from the hypothalamus of the 
neuropepetides CRH and arginine-vasopressin (AVP) into the hypophyseal 
portal blood system. The combined action of CRH and AVP stimulates the 
anterior pituitary gland to secrete peptides derived from the 
proopiomelanocortin transcript, which includes ACTH; this hormone, acting on 
the cortex of the adrenal glands, eventually promotes the synthesis and secretion 
of the GC, the main hormones of stress (Engler et al., 1989; Rivier and Rivest, 
1991). Glucocorticoids regulate the secretion of CRH, AVP and ACTH through 
negative feedback actions on the brain and anterior pituitary gland (Canny et al., 
1989). In humans and many mammalian species, the predominant GC is 
cortisol, whereas in rodents and birds the key GC is corticosterone.  
GC are steroid hormones which have both protective and damaging 
effects on the organism. In the short time they are essential for adaptation, 
maintenance of homeostasis and survival. Yet, over longer time intervals, they 
impose a cost (allostatic load) that can accelerate disease processes or 
participate to pathological changes ranging from immunosuppression, obesity 
and atherosclerosis (McEwen, 2000b).  
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Glucocorticoids exert action in the brain via high affinity Type I 
mineralocorticoid receptors (MR) and low affinity Type II glucocorticoid 
receptors (GR) (De Kloet et al., 1998). In the brain MR are located in the 
hippocampus, a region involved in memory formation and retention, and other 
regions of the limbic system such as lateral septum, amygdala and 
hypothalamus, while GR have a more extensive distribution within the brain, 
being also present in the hippocampus, and most abundant in the hypothalamus 
and in pituitary corticotrophs. At basal levels, GC predominantly bind to MR 
and only slightly occupy GR. In addition, MR are responsible for much of the 
effects of basal and low-stress levels of GC at the onset of the stressors, whereas 
GR largely mediate the effects of high-stress levels of GC, facilitating the re-
establishment of homeostasis when stress levels of GC prevail (De Kloet et al., 
1998; De Kloet, 2004). Alterations in the effectiveness of negative feedback by 
GC have profound effects on the activity of the HPA axis and regulation of 
stress responses, such that aberrant action can increase the vulnerability of the 
individual to stress-induced disorders or disease (De Kloet et al., 1998). There is 
also evidence that changes in the effectiveness of negative feedback by GC 
contribute to attenuate HPA axis responses to stress in some physiological 
states, thereby resulting in stress hyporesponsiveness.  
 
1.1.3. Stress effects on immune system response 
The communication between the central nervous system and the immune system 
occurs via a complex network of signals linking the nervous, endocrine and 
immune systems (Glaser and Kiecolt-Glaser, 2005b). The field of 
psychoneuroimmunology (PNI) has recently produced new insights that help 
understanding the pathophysiological processes resulting from disrupted 
immune system function. Works in this field have established that 
psychological stress disturbs the functional interaction between the nervous and 
immune systems (Glaser and Kiecolt-Glaser, 2005a; Webster Marketon and 
Glaser, 2008; Kiecolt-Glaser et al., 2010; Yang et al., 2010), altering some 
signals, such as cytokines, chemokines and modifying macrophages 
physiological functions (Yang and Glaser, 2002; Webster Marketon and Glaser, 
2008; Yang et al., 2010). In this context, there are two main sources of variation 
that can influence immune system activity and lead to susceptibility to disease. 
These are mainly linked to the characteristics of the individual subject (gender, 
age and species) and to the nature of the stressor itself (intensity, duration and 
perception).  
In order to understand the relationship of psychosocial stressors to the 
immune system, it is useful to distinguish between innate and acquired 
immunity (Segerstrom and Miller, 2004). Innate immunity is an immune 
response characteristic of vertebrates and invertebrates, as well as plants, and 
the basic mechanisms that regulate its functioning are highly conserved. Cells 
involved in the innate immunity represent the first line of host defense during 
infection and, therefore, play a crucial role in the early recognition to destroy 
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the invading pathogens (Medzhitov and Janeway, 2000; Mogensen, 2009). The 
cells involved in natural immunity include: mast cells, eosinophils, basophils 
and the phagocytic cells including macrophages, neutrophils, and dendritic 
cells, and function within the immune system by identifying and eliminating 
pathogens that might cause infection. More in detail, these cells assemble at the 
site of injury or infection, release toxic substances, such as oxygen radicals, that 
damage invaders, and phagocytose both invaders and damaged tissue. Another 
cell involved in natural immunity is the natural killer cell. Natural killer cells 
recognize the lack of a self-tissue molecule on the surface of target cells 
(characteristic of many kinds of virally infected and some cancerous cells) and 
induce their direct cytotoxicity (Chan et al., 2014). These responses result 
important in limiting the early phases of viral infections, before specific 
immunity becomes effective (Andrews et al., 2003; Andoniou et al., 2006), and 
in attacking self-cells that have become malignant (immune surveillance of 
tumors) (Smyth et al., 2000; Smyth et al., 2001).  
The acquired immune system, composed of T and B lymphocytes, is 
characterised by memory or secondary antigen-specific immune responses 
(Taniguchi et al., 2003). These cells are produced in hematopoietic organs, such 
as the bone marrow, spleen and thymus (Abbas et al., 2014). T lymphocytes 
play an important role in cell-mediated immunity. They can be distinguished 
from NK cells and B lymphocytes by the presence of the T cell receptor on the 
cell surface (Webster Marketon and Glaser, 2008). T lymphocytes can be 
divided into subgroups: T-helper cells, T-cytotoxic cells, and T-regulatory cells. 
The main function of T-helper cells is to produce cytokines that direct and 
amplify the rest of the immune response. T-cytotoxic cells recognize antigen 
expressed by cells that are infected with viruses or otherwise compromised 
(e.g., cancer cells) and lyse those cells. T regulatory cells produce anti-
inflammatory cytokines that suppress or downregulate induction and 
proliferation of effector T cells. B cells are involved in humoral immunity and 
produce soluble proteins called antibodies that can perform a number of 
functions, including neutralizing bacterial toxins, binding to free virus to 
prevent its entry into cells, and opsonization, in which a coating of antibody 
increases the effectiveness of natural immunity (Segerstrom and Miller, 2004).  
The transition from innate to adaptive immunity is mediated by 
cytokines, inflammatory molecules, that are released by macrophages, and 
lymphocytes, although they can also be produced by polymorphonuclear 
leukocytes (PMN), endothelial and epithelial cells, adipocytes, and connective 
tissue (Butterfield et al., 2006; Arango Duque and Descoteaux, 2014). 
Cytokines can act in an autocrine, paracrine or endocrine fashion and can be 
subdivided in to proinflammatory (Th1) and antiinflammatory (Th2) cytokines, 
which are produced by type 1 and type 2 helper T cells respectively (Webster 
Marketon and Glaser, 2008). The proinflammatory cytokines include IL-1, IL-2, 
IL-6, IFNγ and tumor necrosis factor α (TNFα) whereas antiinflammatory 
cytokines include IL-4, IL-5, IL-10 and IL-13.  
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Th1 responses result critical for viral clearance, whereas Th2 cells are 
important for immune responses to parasites in mice and in humans 
(Romagnani, 1997; Maldonado-Lopez and Moser, 2001). Th1 and Th2 cells can 
be cross-inhibitory and the balance between Th1 and Th2 cell function or 
cytokine production may be altered by stressor administration (Moynihan, 
2003). Cytokines are the main messengers used by the immune system to 
communicate directly with the neuroendocrine system. In particular, they 
stimulate the secretion of hypothalamic CRH and activate the HPA axis, but this 
effect is blocked by glucocorticoids (Rivest, 2001; Webster et al., 2002; Rhen 
and Cidlowski, 2005). In this context, chronic exposure to GC inhibits both 
innate and adaptive immunity reducing circulating leukocyte counts and 
decreases the production of a large variety of proinflammatory cytokines 
including IL-1β and TNF-α, forming a negative feedback loop. Dysregulation of 
this neuroendocrine loop by hyperactivity or hypoactivity of the HPA axis 
causes systemic changes in inflammation and immunity, increasing 
susceptibility to infections and cancer (Saul et al., 2005; Dhabhar et al., 2012; 
Dhabhar, 2014). 
 
1.1.4. Stress modulates brain plasticity through neurotrophins: focus on 
BDNF 
Brain plasticity refers to the brain’s ability to respond and adapt to 
environmental challenges and encompasses a series of functional and structural 
mechanisms that may lead to neuronal remodelling, formation of novel 
synapses and birth of new neurons. However, in a broader sense, neuronal 
plasticity is intimately linked to cellular responsiveness and may therefore be 
considered as an index of the neuronal capability to adapt its function to a 
different demand. Failure of such mechanisms might enhance the susceptibility 
to environmental challenges, such as stress, and ultimately lead to 
psychopathology. That is to say that the brain, or more specifically, some brain 
structures or circuits, as a consequence of stress, may become more vulnerable 
by loosing progressively (or suddenly) the ability to adapt to challenges and 
maintain their homeostasis.  
According to the concept of allostasis and allostatic load, the duration of 
a stressful experience represents a critical factor in the modulation of brain 
plasticity (McEwen, 2000a). Indeed the same mediators or system involved in 
the adaptation to acute challenges, can also participate in pathological effects 
determined by prolonged repetitive exposure to stressful conditions. In this 
context, many studies have been focused on two limbic brain regions involved 
in the neuroendocrine response: the hippocampus, which has high levels of GR 
and has connections with the amygdala and prefrontal cortex, regions that are 
more directly involved in emotion and cognition, and the hypothalamus, which 
represents the final common pathway integrating different stress inputs. For 
example, a mild stress can enhance learning and memory within hippocampus 
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(Luine et al., 1996) and can activate hypothalamic neurons (Herman et al., 
2008), whereas chronic or severe stressors have detrimental effects leading to 
neuronal atrophy (Sapolsky, 2003; Herman et al., 2008).  
Within this context, neurotrophic factors (NTFs) may play a central 
role, since they are necessary for the normal development, survival, and 
plasticity of neurons. More in detail, besides their classical role in supporting 
neuronal survival, NTFs finely modulate all the crucial steps of network 
construction, from neuronal migration to experience-dependent refinement of 
local connections (Poo, 2001). These functions were first reported based on the 
observation that during the development of the nervous system neuron survival 
depends on the limited amount of specific NTFs secreted by target cells (Huang 
and Reichardt, 2001). However, it is now well established that NTFs are 
important mediators of neuronal plasticity also in adulthood where they 
modulate axonal and dendritic growth and remodelling, membrane receptor 
trafficking, neurotransmitter release, synapse formation and function (Lu et al., 
2005). 
The neurotrophin Brain-derived Neurotrophic Factor (BDNF) is a 
member of the neurotrophin family that has an important role in development as 
well as in adult neuronal plasticity and is abundant in lymbic regions that are 
particularly relevant for mood modulation (Castren et al., 2007). 
Modulation of BDNF by stress was originally shown several years ago 
(Smith et al., 1995). Since then, evidence has been produced demonstrating the 
complex outcome of stress on the BDNF system. Acute stressors can produce a 
significant and transient increase of BDNF mRNA levels in the rat (Marmigere 
et al., 2003) as well as in the prefrontal and cingulate cortex of rats (Molteni et 
al., 2001) and in the frontal lobe of mice (Molteni et al., 2009) exposed to an 
acute restraint stress. If the rapid increase of BDNF expression following a 
single stress may represent a short-term protective mechanism (Rage et al., 
2002; Bramham and Messaoudi, 2005; Chao et al., 2006), a prolonged stressful 
experience may have a detrimental effect on neuroplasticity, because it reduces 
BDNF expression in limbic regions (Smith et al., 1995; Vollmayr et al., 2001; 
Roceri et al., 2002; Nair et al., 2007).  
Interestingly, BDNF may represent an important element in order to 
understand the relationship between stress and behavioural changes associated 
with depression (Castren et al., 2007; Schmidt and Duman, 2007; Cirulli and 
Alleva, 2009). Specifically, BDNF exerts a main role in the etiopathogenesis of 
mood disorders since its down-regulation precipitates behaviours associated 
with anxiety and depression like-behaviours, such as increased behavioural 
despair in the forced swim test and decreased sucrose preference, a measure of 
anhedonia, following stress exposure (Snyder et al., 2011). 
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1.1.5. Animal models of stress and behavioural coping strategies 
The development of animal models of stress has led to greater understanding of 
the role of different stressors and their timing on physiological and behavioural 
regulations.  
Restraint stress results one of the most commonly employed procedures 
to induce stress-related behavioural, biochemical and physiological changes in 
laboratory animals, since immobilization models produce an inescapable 
physical and psychological stress with a low rate of adaptation (Kasuga et al., 
1999). The restraint procedure consists in removing subjects from their home 
cage and putting each of them in a conical 50mL falcon tube, provided with 
holes for breathing, on a laboratory bench under dim light. After immobilization 
stress, animals exhibit higher levels of anxiety in the elevated plus maze and 
other tests of anxiety (Padovan and Guimaraes, 2000; Campos et al., 2010).  
As for social stressors, they are effective in triggering powerful 
physiological and, more importantly, emotional responses in social animals, 
such as rats and mice (Kudryavtseva et al., 1991; Sheridan et al., 2000; 
Bartolomucci et al., 2005; Fuchs, 2005; Miczek and de Wit, 2008; Vialou et al., 
2010). All mammals interact with other individuals. In the wild, rodents may 
encounter competition for resources such as territory, food, and access to mates, 
and even solitary species interact with conspecifics and their chemical cues, if 
only to avoid them in the future. Both aversive and positive interactions are 
relevant features of the social environment. Models of social stress used in 
rodents include social subordination, isolation, and disruption of social 
hierarchy (Blanchard et al., 2001; Chida et al., 2005; Avitsur et al., 2009). 
Indeed, in the highly social, group-living rodent species, social competition 
takes place and specific hierarchies are present that allow discriminating 
dominant from subordinate subjects (Bartolomucci et al., 2001; Blanchard et al., 
2001). In this context, social stress can be obtained disrupting the social 
structure, for example, by replacing one mouse with a novel unfamiliar subject 
(Avitsur et al., 2003; Avitsur et al., 2009). 
At the opposite extreme, solitary housing can be a potent stressor for 
highly social species such as rodents (Heinrichs and Koob, 2006). In both rats 
and mice, extended (weeks-months) solitary housing produces an “isolation 
syndrome”, consisting of hyperadrenocorticism, reduced body weight, altered 
blood composition, and enhanced pain responsiveness, among other outcomes 
(Hatch et al., 1965; Valzelli, 1973). These changes coincide with alterations in 
behaviour including increased aggression, reduced mating behaviour, impaired 
learning and increased pain sensitivity (Valzelli, 1973).  
Within a species, the capacity to cope with environmental challenges 
largely determines individual survival in the natural habitat. The success of the 
coping behaviour can be measured by its effectiveness in reducing physiological 
measures of stress or by its effectiveness in removing an adverse situation. 
Active coping strategies are used when escape from threat is possible, and the 
autonomic changes associated with these active strategies are mediated 
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predominantly by sympathetic activation (hypertension, tachycardia). This is the 
fight-or-flight response originally described by Cannon (Chrousos and Gold, 
1992). Passive coping strategies, such as immobilization or freezing, are usually 
elicited when threat is inescapable, and are usually characterised by autonomic 
inhibition (hypotension, bradychardia), and a more pronounced increase in the 
neuroendocrine response (activation of the HPA axis and increased GC 
secretion). Under natural conditions, immobility is a highly selected response 
because movement makes the rodents more detectable to predators and because 
predators are much more likely to attack moving than still prey (Bolles and 
Fanselow, 1980). This type of passive response was originally described by 
Engel and Schmale as a conservation-withdrawal strategy (Engel and Schmale, 
1972). Coping strategies concern also displacement/de-arousal behaviours, 
which may allow an individual temporarily to “cut-off” attention from a 
threatening stimulus, and this short-term diversion of attention could reduce the 
negative arousal associated with the stimulus. In this context, rodents perform 
self-grooming (rubbing the body with paws or mouth and rubbing the head with 
paws) and digging (animal digs the sawdust with the forelimbs, often kicking it 
away with the hind limbs) behaviours.  
It must be taken into account that acute or chronic stressors affect 
differentially the capacity of an individual to cope. If the stress response is 
inadequate or excessive and prolonged, the cost of reinstating homeostasis 
might become too high, leading to allostatic load. In this context, chronic 
exposure to inescapable physical and psychological stress, such as restraint and 
social isolation, results associated to deregulation of HPA axis activity and 
limbic function, finally promoting endophenotype of depression (McEwen, 
2000a; Herman, 2013). Mice exposed to a series of chronic stressors exhibit 
increased signs of anxiety and depression- like behaviours, including increased 
passivity in a forced swim test, reduced aggression in a social interaction test, 
delayed approach to food in a novel environment (Tannenbaum et al., 2002). 
 
 
1.2. PSYCHONEUROENDOCRINE REGULATIONS AND CANCER 
 
1.2.1. Stress affects cancer progression 
Cancer is a multifactorial disorder caused by both internal (inherited mutations, 
hormones and immune conditions) and environmental factors (smoke, diet, 
radiation, stress). In this context, although most cancer research is mainly 
focused on molecular and cellular interactions, there is now clear evidence that 
psychological factors can influence disease progression. Stressful events, in 
particular, can unleash a signalling cascade accelerating tumor onset and 
progression.  
Lack of social support, a well known psychosocial stressor, has been 
associated with pain, fatigue, lethargy and higher inflammation among cancer 
patients (Gagliardi et al., 2009; Hughes et al., 2014), while in mouse models of 
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cancer, exposure to social isolation alters tumor and spleen macrophage 
populations, potentiating tumor growth and metastasis (Hermes et al., 2009; 
Williams et al., 2009; Madden et al., 2013; Volden et al., 2013). It must be 
taken into account that 15-50% of breast cancer patients meet diagnostic criteria 
for anxiety and depression (Burgess et al., 2005) and that the tumor itself can 
produce depressive symptoms through the expression of cytokines and growth 
factors, generating a positive feedback loop between coping style and cancer 
progression (Sephton et al., 2009). Depressed metastatic breast cancer patients 
are often characterised by blunted cortisol awakening responses and by 
dysregulation of the HPA axis, reflecting a physiologic profile associated with 
chronic stress (Sephton et al., 2009). These endocrine changes have the 
potential to override the immune defense or act directly on the tumor 
microenvironment, affecting cancer progression.  
Many studies suggest that prolonged exposure to stress - with a 
persistent activation of the HPA axis and the consequent suppressed activity of 
the immune system (both in humans and in animal models), mediated by 
glucocorticoid (GC) hormones - can render subjects more susceptible to disease, 
including neoplastic processes (Cavigelli et al., 2008).  
In addition to classic neuroendocrine factors, BDNF is produced by 
different cell types including immune cells, adipocytes, endocrine and 
endothelial cells and has a key position in integrating neural, immune and 
endocrine responses to stress (Cirulli and Alleva, 2009; Capoccia et al., 2013). 
This neurotrophin is implicated in the pathophysiology of the nervous system, 
including the etiopathogenesis of depression, while in the periphery it regulates 
metabolic responses to stress and has been recently involved in tumor 
development and progression (Cirulli and Alleva, 2009; Yang et al., 2012; Liu 
et al., 2014).  
In addition to the neuroendocrine axis, stress activates the sympathetic 
nervous system (SNS), which acts through release of the catecholamines 
norepinephrine (NE) and epinephrine (EPI) from sympathetic noradrenergic 
nerves and from the adrenal medulla. Beta-adrenergic signalling regulates the 
biological activity of several cancer-relevant cell types including epithelial cells, 
adipocytes and most lymphoid and myeloid immune cells. Hypothalamic BDNF 
can lead to activation of sympathetic innervation of white adipose tissue, which 
can, in turn, affect tumor growth through the production of multiple mediators 
such as cytokines, chemokines, adipokines, estrogen and growth factors.  
 
1.2.2. Transgenic mouse models of breast cancer 
The pathogenesis of breast cancer involves multiple genetic events, including 
gain of function mutations in proto-oncogenes, which are involved in 
supporting cell growth, division and survival, and loss of function mutations in 
so called 'tumor suppressor' genes, which are involved in preventing 
unrestrained cellular growth (Hutchinson and Muller, 2000). The majority of 
gain of function mutations in human primary breast cancers involves 
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amplifications in one of three chromosomal regions, the c-myc and erbB-2 
proto-oncogenes or the chromosomal band 11q13 (Lidereau et al., 1988). Loss 
of function mutations in primary human breast cancers includes changes in the 
known tumor suppressor p53 as well as in the familial cancer markers of the 
BRCA gene family (Hutchinson and Muller, 2000). Many mouse systems exist 
to address the significance of these mutations in the pathogenesis of breast 
cancer and a number of transgenic promoters have been employed to target 
transgene expression to the mammary gland (Hutchinson and Muller, 2000; 
Fantozzi and Christofori, 2006; Caligiuri et al., 2012).  
A consistent number of the transgenics generated have employed the 
mouse mammary tumor virus long terminal repeat (MMTV) which is active 
during mammary development (Hutchinson and Muller, 2000; Sakamoto et al., 
2012; Peng et al., 2013). One of the known oncogenes, which is expressed 
under control of the MMTV promoter to initiate or modulate breast 
carcinogenesis in mice, is ErbB2/Neu (Fantozzi and Christofori, 2006; Ursini-
Siegel et al., 2007). ErbB-2 is a member of the epidermal growth factor (EGFR) 
family of receptor tyrosine kinases (RTKs) (Roskoski, 2014). This family 
consists of four members (HER1-4) that belong to the ErbB lineage of proteins 
(ErbB1-4) and which is ubiquitously expressed in epithelial, mesenchymal, and 
neuronal cells and their cellular progenitors (Olayioye et al., 2000; Roskoski, 
2014). The ErbB-2 occurs in 20-30% of human breast cancers and its 
amplification and subsequent overexpression strongly correlates with a negative 
clinical prognosis in both lymph node positive (Hynes and Stern, 1994; 
Mansour et al., 1994; Ravdin and Chamness, 1995; Shah and Chen, 2011) and 
node-negative (Andrulis et al., 1998; Ozcelik et al., 2007) breast cancer patients. 
Further evidence that overexpression of ErbB-2 results in an aggressive tumor 
type stems from studies showing that elevated ErbB-2 expression is observed in 
many in situ and invasive human ductal carcinomas but is rarely observed in 
benign breast disorders, such as hyperplasias and dysplasias (Allred et al., 1992; 
Mansour et al., 1994).  
Overall thus, multiple transgenic mouse models have confirmed a direct 
role for ErbB-2 in mammary tumorigenesis, each with their own level of 
relevance to the human disease. MMTV-driven overexpression of the oncogene 
neu or an analogous ERbB-2 transgene engineered to possess a similar 
activating mutation within the transmembrane domain results in the formation 
of mammary adenocarcinomas that histologically resemble human disease 
(Bouchard et al., 1989; Guy et al., 1996; Ursini-Siegel et al., 2007). In 
particular, the FVB-Tg(MMTV-Erbb2) transgenic mice express the activated rat 
c-neu oncogene (Erbb2) under the control of the MMTV long terminal repeat 
(LTR) promoter. The activated, or transforming, version of the rat c-neu 
oncogene has a valine to glutamic acid substitution at acid 664 (Val664 to 
Glu664) and this transgene is microinjected into fertilized FVB/N eggs 
(http://jaxmice.jax.org/strain/005038.html). The FVB-Tg(MMTV-Erbb2) 
transgenic mice develop hyperplasia at 5 months and focal adenocarcinoma and 
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lung metastases at 7 months, helping to resemble the postmenopausal condition 
and to allow chronic stress treatment. 
 
 
1.3. RATIONALE AND OBJECTIVES  
 
1.3.1. Current state of the art and statement of the problem  
The literature reviewed so far indicates chronic stress as a vulnerability factor 
for physical as well as psychological health, although the underlying 
mechanisms are still unclear. The brain is a primary mediator and target of 
stress resiliency and vulnerability, because it determines what is threatening and 
because it regulates the behavioural and physiological responses to a given 
stressor through its role in HPA axis functioning and feedback. The connection 
between central stress response pathways and peripheral targets involves a 
number of neurochemical and/or inflammatory factors that ultimately affect 
neuronal functioning and/or survival as well as adaptive physiological responses 
that allow fighting against external challenges. One of the most representative 
players implicated in these events is BDNF, which is involved in synaptic and 
morphological plasticity of the brain, both during development as well as at 
adulthood. This neurotrophin is implicated in the pathophysiology of the 
nervous system, including the etiopathogenesis of depression, while in the 
periphery it regulates metabolic responses to stress. While there is now a clear 
evidence for a potential physiological connection among stressful events, 
neuroendocrine and immune response and behavioural phenotype, the multiple 
mediators, the qualitative and temporal features of stress must be studied more 
extensively in order to clarify the mechanisms through which stress acts on 
health outcomes. 
Stress physiology overlaps to a great extent in humans and mice, thus 
preclinical models can guide and refine hypothesis- driven clinical research 
questions. The animal models here used have been selected to identify the key 
players in a network made up of specific aspects of the social context, copying 
styles, neuroendocrine mechanisms and immune responses. It is important to 
consider that chronic stress experience could impinge upon an individual for 
weeks, months or even years. Thus we used stressors of different lengths and 
strengths known to affect neuro-immune functioning to model human 
experiences.  
The general aim of the work presented in this thesis was to characterise 
how quality and timing of stressors differentially impact on behavioural, 
neuroendocrine and immune profile in animal models (mice). 
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1.3.2. Rationale of the studies 
I. Study the relationship between neuroendocrine activation (circulating 
corticosterone and central BDNF levels) and a wide array of depression- 
and anxiety-like behaviours (anhedonia, behavioural despair, generalised 
and social anxiety) resulting from exposure to chronic stress. To this end, 
adult C57BL/6J male mice were exposed to either chronic disruption of 
the social structure (SS), to a stable social structure (SG) or to social 
deprivation (SD), a condition lacking social stimuli. 
II. Characterise central and peripheral effects of different stressors, applied 
for different time lengths, on neuroendocrine and immune responses in 
adult male C57BL/6J mice. Specifically, we compared the effects of 
repeated (7 versus 21 days) restraint stress and social stress on 
neuroendocrine (circulating corticosterone) and immune (circulating 
cytokines and splenic apoptosis) function and on a marker of brain 
plasticity (hippocampal BDNF) in order to identify a specific 
neuroendocrine profile in response to a selective type of stress. 
III. Investigate the effects of social isolation and restraint stress on a 
transgenic mouse model of breast cancer. Our aim was to characterise the 
mechanism through which stressful events affect tumor growth, 
hypothesising that they would activate neuroendocrine pathways, 
thwarting immune function and modifying the gene expression of central 
BDNF and of adipose tissue-derived adipokines, finally promoting tumor 
progression. A further aim of this study was to assess whether changes in 
tumor biology, resulting from stress exposure, would also be accompanied 
by an increase in endophenotypes of depression, previously validated in 
animal models, such as anhedonia.  
 
1.3.3. Experimental approach and outline of the thesis 
In Chapter 2 and 3 we report two studies aimed at characterising a behavioural-
neuroendocrine-immune profile in a mouse model of stress. Since natural 
fluctuations in sex hormones have enormous influences on neuroendocrine 
function, both these studies were performed on C57BL/6J adult male mice. This 
strain has been one of the most commonly used in translational research because 
its genome shares 99% homology with the human genome (Waterston et al., 
2002). 
Chapter 2 describes a study aimed at assessing the effects of stress on 
behavioural, neuroendocrine and neurobiological responses. In particular, mice 
underwent either to a Chronic Social Stress (SS) consisting of a disruption of 
the social structure, or to Social Deprivation (SD) obtained by prolonged 
individual housing (Valzelli, 1973). As for social stress, it has been widely 
reported that the presence of social odour cues emanating from the mouse body, 
originating largely from their urine, are involved in the advertisement of 
dominance over a defended territory (Gosling, 1990; Hurst, 1990). Therefore by 
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disrupting the social group (SS) we attempted to mimic the presence of an 
intruder in the territory, which might lead to a change in the social structure. In 
particular, we compared the selected stressful procedures in their ability to 
induce a depressive-like state by measuring behaviours such as levels of 
anhedonia (preference for sucrose solution) and behavioural despair (Forced 
Swim Test). In addition generalised anxiety (Elevated Plus Maze), social 
anxiety (Social Interaction Test), and the emotional response to a novel 
environment (Open Field test) were also observed. Levels of BDNF protein as a 
marker of vulnerability to stress-induced depression were measured in the 
limbic system.  
In Chapter 3 we focused our attention on the comparison between the 
response to social stress and the response to a different, psychophysical stress. 
The main aim of this study was, in fact, to characterise qualitative and temporal 
features of this two different stressors and to extend the range of mediators 
analysed and the peripheral targets, to evaluate more extensively the role of 
acute versus chronic stressors on neuroendocrine and immune function. 
Specifically, experimental subjects were divided into three groups: 7 days stress 
(restraint stress or social stress) 21 days stress (restraint stress or social stress), 
and unhandled controls (CTRL, subjects left undisturbed in their home cage). 
Corticosterone levels, circulating cytokines, splenic apoptosis and hippocampal 
BDNF levels were assessed to define a “complete picture” of individual 
response. The central nervous system and the immune system are known to be 
engaged in an intense bidirectional crosstalk which can be affected by stress and 
which involves multiple mediators, including cytokines and growth factors 
(Hayley et al., 2005). As an example, the immune signalling cytokines, 
particularly the proinflammatory ones, such as IL-6 or TNF- , are elevated 
following stress exposure and can thwart brain plasticity eliciting depressive 
symptoms, which are amenable to antidepressant treatment (Hayley et al., 
2005). However, the directionality of the effects of stress is still a matter of 
intense investigation: for instance, GC released in response to stress can act 
both enhancing and inhibiting immune responses and by decreasing or 
increasing levels of neurotrophins (Smith et al., 1995; Marmigere et al., 2003; 
Dhabhar, 2008). Factors such as the duration (acute versus chronic) of stress as 
well as the time of exposure to GC, relative to the activation and time course of 
the immune response, might differently impact health outcome (Dhabhar, 
2008).  
In Chapter 4 we tested the effects of social isolation and restraint stress on 
tumor progression in a transgenic mouse model of breast cancer. For this study 
we choose mice of to FVB/NJ (FVB) strain which is more susceptible to 
mammary tumors than the C57BL/6 strain (Davie et al., 2007; Taneja et al., 
2009). More in detail, experimental subjects were ErbB-2(Neu)TgMMTV-
ErbB-2 (FVB background) since human breast cancer models using MMTV-
LTR mice have often been created in the FVB strain, due to its high 
productiveness of offspring (Davie et al., 2007; Taneja et al., 2009). In this case 
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mice were all females because breast cancer incidence is about 100 times more 
common among women than men. Half of subjects were socially isolated at 
weaning to model long-term stress that could accompany an individual 
chronically during life. In addition, to assess whether a further stressful 
challenge experienced (such as the diagnosis of cancer in humans) would 
worsen the effects upon a long-term vulnerability, experimental subjects 
underwent restraint stress by the time they started developing tumors (5 
months). At the end of the stress procedures peripheral (HPA axis activity, 
adipose tissue leptin and adiponectin gene expression, splenocytes apoptosis 
and cytokines levels) and central (hypothalamic BDNF gene expression) 
responses were assessed and related to tumor onset and development in order to 
characterise and clarify the mechanisms through which the environment could 
act on disease outcome. In addition, it must be taken into account that 
depressive symptoms often accompany breast cancer patients as a result from 
situational fear related to diagnosis and prognosis, or may be directly related to 
the effects of the tumor. In this regard, Lamkin and co-workers have shown an 
increase in endophenotypes of depression following tumor implantation 
(Lamkin et al., 2011). Thus a further aim of this study was to assess whether 
changes in tumor biology, resulting from stress exposure, would also be 
accompanied by an increase in endophenotypes of depression, previously 
validated in animal models, such as anhedonia. All data are discussed in 
Chapter 5. 
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ABSTRACT 
Stress is a main risk factor that can trigger psychiatric disorders, including 
anxiety and major depression. Neurotrophins, such as Brain-Derived 
Neurotrophic Factor (BDNF), have been identified as neuroendocrine effectors 
involved in the response to stress and in the neurobehavioural changes 
associated with depression. Aim of this paper was to study the relationship 
between neuroendocrine activation (circulating corticosterone and brain BDNF 
levels) and a wide array of depression- and anxiety-like behaviours (anhedonia, 
behavioural despair, generalised and social anxiety) resulting from exposure to 
chronic stress. To this end, 3-month-old C57BL/6J male mice were exposed to 
either chronic disruption of the social structure (SS), to a stable social structure 
(SG) or to social deprivation (SD), a condition lacking social stimuli. Results 
show that, despite not developing anhedonia (decreased preference for a sucrose 
solution), SD mice were characterised by increased emotionality and 
hypothalamic-pituitary-adrenal axis reactivity in addition to reduced BDNF 
levels. By contrast, SG and SS mice showed increased anhedonia accompanied 
by no alterations in the behavioural and neuroendocrine profile. The results here 
reported indicate that mice exposed to different social housing conditions use 
different behavioural strategies to cope with external challenges. In addition 
they suggest that social deprivation might represent a stressful condition 
triggering the emergence of both anxiety- and depression-like behaviours and 
clearly indicate BDNF as a main neurobiological variable mediating these 
responses. 
 
Keywords: Stress; Anxiety; Depression; Social deprivation; Anhedonia; BDNF 
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2.1. INTRODUCTION 
Stress is a main risk factor for psychopathology as chronic exposure to severe 
physical or emotional stimuli can precipitate major depression in vulnerable 
individuals (Kendler et al., 1999; Cirulli et al., 2009a). Clinical evidence 
indicates that in depressed patients, emotional arousal, cognitive abnormalities 
and vulnerability to psychotic episodes are associated to a hyperactive 
hypothalamic—pituitary— adrenal (HPA) axis (de Kloet et al., 2007). In 
addition to glucocorticoids (GCs), neurotrophins, such as Brain-Derived 
Neurotrophic Factor (BDNF), have been identified as neuroendocrine effectors 
involved in the response to stress and to neurobiological and behavioural 
changes associated with depression (Pezawas et al., 2004; Duman and 
Monteggia, 2006; Castren et al., 2007; Schmidt and Duman, 2007; Brunoni et 
al., 2008; Cirulli and Alleva, 2009; Cirulli et al., 2009b, 2010b). Indeed, 
decreased blood BDNF levels characterise subjects diagnosed as major 
depressives, antidepressants reverting this neurobiological change (Shimizu et 
al., 2003; Karege et al., 2005; Duman and Monteggia, 2006; Sen et al., 2008). 
In rodents, chronic stress decreases the expression of this neurotrophin, which 
can lead to neuronal atrophy in the hippocampus and other brain structures 
(Schmidt and Duman, 2007), while direct hippocampal infusion of BDNF 
produces anxiolytic and antidepressant effects (Siuciak et al., 1997; Shimizu et 
al., 2003; Cirulli et al., 2004). In addition, a very recent study reports that 
knocking-down BDNF in specific rat’s brain sites precipitates behaviours 
associated with depression such as preference for a sucrose solution (Taliaz et 
al., 2010). 
 Progress in understanding the pathophysiology of major depression and 
treatment development would greatly benefit from appropriate animal models 
(Nestler and Hyman, 2010). The chronic mild stress (CMS) paradigm has been 
developed in rodents to simulate unpredictable stress that may occur in 
everyday life (Willner et al., 1987). This procedure is effective in inducing 
neurobehavioural disturbances, such as a reduction in responsiveness to a 
reward, which has been compared to anhedonia, one of the core symptoms of 
human depression (DSM-IV, American-Psychiatric- Association, 1994). 
Moreover, all the behavioural alterations induced by CMS can be reversed by 
chronic antidepressant administration (Willner et al., 1987). Although the CMS 
paradigm appears to be able to reproduce a fair number of depression-like 
symptoms, data relating specific physiological changes with the behavioural 
phenotype resulting from exposure to this procedure are scattered and often 
conflicting. As an example, Larsen and colleagues, despite a behavioural 
depressive-like phenotype, found an increase, rather than the expected decrease, 
in BDNF mRNA expression in the hippocampus of rats exposed to chronic 
unpredictable stress (Larsen et al., 2010). In addition, results from studies 
assessing anxiety-related behaviours in CMS animal models of depression are 
rather ambiguous, since some authors report decreased (Kopp et al., 1999) while 
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others find increased anxiety after this procedure (Kompagne et al., 2008). 
These discrepancies might depend upon the interplay among different 
neurobiological variables known to affect anxiety- and depression-like 
behaviours including HPA axis activation and levels of serotonin (5-HT) and 
BDNF (Nutt and Stein, 2006) as well as upon the ultimate length of the stress 
period. Indeed, although there are sufficient and significant differences between 
anxiety and depression, which support the view that they are independent 
clinical entities, there is also evidence that these psychopathologies co-exist and 
that anxiety typically precedes depressive disorders (Ballenger, 1999; Ninan, 
1999; Nutt and Stein, 2006). Such co-morbidity is due to the fact that these two 
pathologies share common neurobiological mechanisms, as increased 5-HT 
levels, associated with administration of selective 5-HT reuptake inhibitors 
(SSRIs), are not only able to reduce depressive symptoms but also to reduce 
anxiety levels (Cryan and Holmes, 2005).  
Social stress in humans represents a major etiological factor in the 
development of emotional disorders, including depression (Leskela et al., 2006; 
McEwen and Gianaros, 2010). Based on the notion that changing the social 
structure in a group of mice is a stressful event, especially if this is repeated 
over time (Avitsur et al., 2002; Schmidt et al., 2010), we chose such paradigm 
to increase the chance of stimulating behavioural and neuroendocrine responses 
that have been shaped by evolutionary processes. With this study we aimed at 
developing a comprehensive and ethologically relevant experimental method to 
induce chronic stress in mice and to investigate its effects on the interplay 
among behavioural, neuroendocrine and neurobiological aspects. More in detail, 
adult male mice (age 3 months), of the C57BL/6J strain, underwent either a 
Chronic Social Stress (SS), consisting of an experimentally induced disruption 
of the social structure, or group-housing in a stable social arrangement (SG). It 
is widely reported that the presence of social odour cues emanating from the 
mouse body, originating largely from their urine, are involved in the 
advertisement of dominance over a defend territory (Gosling and McKay, 1990; 
Hurst, 1990). Therefore by changing the composition of the social group (SS 
condition) we mimicked the presence of an intruder in the territory, which 
might lead to a change in the social structure. However, also the maintenance of 
a stable social structure may represent a source of stress (Avitsur et al., 2003). 
In fact, it has been shown that group-housed mice show altered behavioural, 
endocrine and immune indices of stress (Sgoifo et al., 2001). In particular, 
Bartolomucci et al. (2002) have provided evidence that lack of 
familiarity/relatedness among cage-mates might be regarded as a main source of 
stress. Thus, we compared SS and SG to a further condition, i.e. social 
deprivation (SD). This condition, consisting of prolonged individual housing, is 
characterised by the lack of social stimuli and, if prolonged, might result in the 
so-called ‘‘isolation syndrome’’ (Valzelli, 1973).  
The effectiveness of such procedures to activate the neuroendocrine 
system was assessed by measuring the activation of the HPA axis through 
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plasma levels of corticosterone (CORT). We hypothesised that, following 
stress, a combination of anxiety and depressive-like behaviours might become 
manifest in the experimental subjects. Thus we selected those tests which might 
be more appropriate (according to previous data) to discriminate between these 
two. To this aim we compared the selected stressful procedures in their ability 
to induce a depressive-like state was assessed by measuring behaviours such as 
levels of anhedonia (preference for sucrose solution) and behavioural despair 
(Forced Swim Test). In addition generalised (Elevated Plus Maze), social 
anxiety (Social Interaction Test) and the emotional response to a novel 
environment (Open Field test) were also observed. Levels of BDNF protein 
were measured in the limbic system as a possible marker of vulnerability to 
stress-induced depression. 
 
 
2.2. MATERIALS AND METHODS 
 
2.2.1. Animals 
Experimental subjects were 44 adult male mice of the C57BL/6J strain that 
were purchased from a commercial breeder (Charles River, Calco, Italy). Upon 
arrival all animals were singly housed in the same room provided by air 
conditioning (temperature 21 ± 1 8C, relative humidity 60 ± 10%), in 
transparent Plexiglas cages (29 cm x 12 cm x14 cm), under a reversed 12/12 h 
light/dark cycle with lights off from 0800 to 2000 h. Pellet food (standard diet 
Altromin-R, purchased from Rieper, Italy) and tapwater were continuously 
available. Animals were left undisturbed for 1 week before the beginning of the 
experimental procedure. At the end of this period animals were allowed to 
habituate to a sucrose solution in order to establish an individual baseline. When 
the baseline was established mice were assigned to 3 conditions: two group- 
housing (social stress - SS, n = 16; social group - SG, n = 16) and one 
individual-housing condition (social deprivation - SD, n = 12); home cages for 
grouped mice had the following dimensions 37 cm x 21 cm x 19 cm. Sucrose 
preference was assessed once a week, during 3 weeks (day 0 - baseline, day 7, 
14 and 21). At the end of the third week of stress, 8 mice were randomly 
selected from each social condition to undergo a battery of behavioural tests 
aimed at assessing the emotional response to a novel environment (Open Field - 
OF), depressive-like behaviours (Forced Swim Test - FST), generalised 
(Elevated Plus Maze - EPM) and social anxiety (Social Interaction Test - SIT). 
During the behavioural assessment the groups/housing conditions (SD, 
SG and SS) were maintained until the brief (24 h) social isolation preceding the 
SIT. In particular, on the first day of behavioural testing mice underwent Open 
Field (0930 - 1130 h) and four hours later experimental subjects were assessed 
in the Elevated Plus Maze (1530 - 1730 h). On the next day a first Forced Swim 
Test session was performed, followed by a second session 24 h later (0930 - 
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1030 h). On the following day mice underwent an acute social challenge (Social 
Interaction Test) between 1700 and 1800 h. Before the beginning of behavioural 
tests, all subjects were moved to the testing room (by the experimenter) and left 
there to habituate for 1 h. Behavioural performances were video recorded and 
the behavioural analysis was carried out from the videotape by an observer 
blind to the social condition, using commercial software (‘‘The Observer 3.0’’). 
At the end of each behavioural session apparatuses were cleaned by a cotton 
pad wetted with a 50% solution of ethanol and water. All behavioural tests were 
conducted under dim red light (1 lx) between 0930 and 1730 h (i.e. during 
mice’s active-period) except for the Social Interaction Test which was used as a 
social challenge to assess CORT levels during the circadian trough (i.e. between 
1700 and 1800 h). In addition, CORT levels were assessed in response to the 
Social Interaction Test. Ten minutes following the end of this test (i.e. 30 min 
from the beginning) subjects were sacrificed (between 1730 and 1830 h), brains 
were dissected out and BDNF levels measured in the hypothalamus, 
hippocampus, frontal cortex, striatum and midbrain. Moreover, adrenal glands 
were also dissected out, and the ratio of adrenal weight to body weight was 
calculated in order to provide indirect evidence of hypercorticism-related 
hypertrophy. All behavioural tests, CORTand BDNF measurements were 
conducted on 8 subjects per group randomly chosen. The number of subjects 
was defined on the basis of the distribution of the dependent variables to be 
assessed and the experimental design, with a level of significance Alpha = 0.05 
in a two-tailed test and a power of 1- Beta = 0.80. 
Animal handling and experimental procedures were performed in 
accordance with the EC guidelines (EC Council Directive 86/609 1987) and 
with the Italian legislation on animal experimentation (Decreto L.vo 116/92). 
 
2.2.2. Experimental procedures 
2.2.2.1. Sucrose Preference Test - SPT. One week following arrival, 
experimental subjects underwent 7 days of familiarisation with a novel sucrose 
solution in order to establish the individual preference. During this phase 
(familiarisation) mice were housed individually and each cage was provided by 
two bottles, one containing fresh tap-water and one containing a 4% sucrose 
solution (Pothion et al., 2004; Lewis et al., 2005). Bottles were daily weighed in 
order to monitor liquid consumption and switched to balance the effect of side 
preference in drinking behaviour, which was reported to be of importance for 
the correct evaluation of sucrose preference (Kant and Bauman, 1993; 
Strekalova et al., 2004). 
The sucrose preference was calculated only on the last day (day 7) of the 
sucrose exposure period following this procedure: mice were deprived of food 
and water for 5 h (from 0900 to 0200 h), soon after they were provided again 
with two bottles either with tap-water or with a fresh sucrose solution for 1 h (in 
the absence of food). Sucrose preference was then calculated as follows: % 
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sucrose preference = (sucrose solution intake x 100)/(water intake + sucrose 
solution intake). Sucrose consumption was derived from bottles’ weight. 
Following the establishment of the sucrose consumption baseline (day 0), on the 
days anhedonia was assessed (day 7, 14 and 21), SG and SS mice were singly 
housed for 5 h in order to score individual consumption, while SD mice did not 
change their social condition. 
 
2.2.2.2. Chronic Social Stress - CSS. Mice were assigned to 3 different 
conditions: SS, SG or SD. More in detail, SS mice (n = 16) were ear-marked 
and housed into 4 cages (4 mice/cage) and social structure was disrupted twice a 
week for three weeks by replacing one mouse with a novel unfamiliar one 
selected randomly from another cage. Sawdust was replaced at the same time in 
each cage. Mice in the SG condition (n = 16) were also housed in groups of 4 
mice/cage however members of each group remained always the same, possibly 
leading to a stable social structure. Cages were cleaned and sawdust replaced 
twice a week mimicking the handling procedure which the SS group was 
subjected to. SD mice (n = 12) were individually housed and cages also cleaned 
and sawdust replaced once a week. 
 
2.2.2.3. Open Field - OF. Mice were individually placed in the centre of a cubic 
arena (open field box 44 cm x 44 cm x 44 cm) made of grey Plexiglas and 
allowed to freely explore for 20 min; during the last 5 min of the test a novel 
object (a 50 ml glass beaker) was introduced in the centre of the arena. The 
open field box was ideally divided into 25 squares and ideally partitioned into a 
central portion (26.4 cm x 26.4 cm) and a peripheral one, identified as the 
remaining part of the arena. When data were analysed, each session was 
subdivided in 4 time blocks (tb) and the time spent in each portion of the arena 
as well as latency, frequency and duration of locomotion (crossings of squares), 
exploratory activity (sniffing and rearing), risk assessment (stretch-attend 
posture - SAP), self-directed behaviours (self-grooming) and object exploration 
(sniffing and touching) were scored. Behaviours were defined as follows: 
- crossing, crossing the square limits with all paws; 
- sniffing, self explanatory; 
- rearing, standing on the hind paws; 
- stretch-attend posture, exploratory posture in which the body is stretched 
forward and then retracted to the original position without any forward 
locomotion; 
- self-grooming, rubbing the body with paws or mouth and rubbing the head 
with paws. 
When the stimulus object was present, latency to the first contact and sniffing 
and frequency of contacts and sniffing of the object were also scored. 
 
2.2.2.4. Elevated Plus Maze - EPM. The Elevated Plus Maze was made of two 
open arms (30 cm x 5 cm x 0 cm) and two closed arms (30 cm x 5 cm x 15 cm) 
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that extended from a common central platform (5 cm x 5 cm). Each arm was 
ideally divided into 4 portions in order to facilitate scoring of locomotor activity 
(crossings, see below). The apparatus, made of Plexiglas (grey floor, clear 
walls), was elevated to a height of 60 cm above the floor. Mice were 
individually placed on the central platform facing an open arm and allowed to 
freely explore the maze for 5 min. Behavioural parameters observed were: 
frequencies of total, open and closed entries (arm entry = all four paws into an 
arm), % open entries [(open/total) x 100], and time spent in open and closed 
parts of the maze (File, 2001). Furthermore, we also scored latency, frequency 
and duration of crossing, sniffing, rearing, self-grooming (for a detailed 
description see Section 2.2.2.3.), head dipping (HED, exploratory movement of 
head and shoulders over the edge of the maze) and SAP. 
 
2.2.2.5. Forced Swim Test - FST. Mice were tested according to the Porsolt’s 
procedure (Porsolt et al., 1977). Each experimental subject was gently placed 
into a cylindrical glass (20 cm Ø, 40 cm height), filled with 25 cm of water at a 
temperature of 26 ± 1 °C for 6 min on 2 consecutive days with a dim light 
illumination (1 lx). When removed from the water, mice were allowed to dry for 
5 min under red light. Twenty-four hours later, a second session took place and 
latency, frequency and duration of the following behavioural responses were 
scored: struggling (vigorous attempts at climbing the walls of the cylinder); 
swimming (active swimming around) and floating (total absence of movement). 
 
2.2.2.6. Social Interaction Test - SIT. A Social Interaction Test was used as a 
social stressful challenge in order to test the activity of the HPA axis and to 
assess social anxiety. The night before the test all subjects were placed in a 
holding cage to stimulate social interactions (Terranova et al., 1993; Cirulli et 
al., 1996; Panksepp et al., 2007). Experimental subjects were placed in a novel 
cage, identical to the holding cage, ideally subdivided in three equal parts, with 
an unfamiliar conspecific of the same strain, weight and sex that had been 
previously isolated (standard opponent). Standard opponents were marked by a 
yellow, scentless and nontoxic paint 30 min before testing, in order to 
discriminate the experimental subject from the unfamiliar conspecific during 
data collection. The maximum length of social encounters was 20 min; by the 
time of behavioural observation, each session was subdivided in 4 tb and 
frequency and duration of environmental exploration (sum of crossing, sniffing 
and wall rearing), social investigation (sum of body, nose and ano-genital 
sniffing), affiliative behaviours (allogrooming and following) and displacement/ 
de-arousal behaviours (sum of digging and self-grooming) were scored. 
Behaviours were defined as follows: 
- wall rearing, animal stands on its hind limbs and touches the walls of the cage 
with the forelimbs; 
- body sniffing, sniffing any other area of the body of the opponent; 
- nose sniffing, sniffing the head and the snout region of the opponent;  
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- ano-genital sniffing, sniffing the ano-genital area of the opponent; 
- allogrooming, grooming the opponent; 
- following, experimental subject follow the standard opponent;  
- digging, animal digs the sawdust with the forelimbs, often kicking it away 
with the hind limbs. 
For crossing, sniffing and self-grooming see Section 2.2.2.3.  
Animals were blood sampled by tail nick, for basal CORT levels, the 
night (1730 - 1830 h) before the last Sucrose Preference Test. At the end of the 
social challenge (1730 - 1830 h), all subjects were sacrificed, trunk blood was 
collected for CORT assessment and tissues dissected out (brain regions and 
adrenals) and immediately frozen until quantification of BDNF. 
 
2.2.2.7. Radioimmunoassay for corticosterone determination - RIA. Blood 
samples (100 ml, approximate volume) were collected individually in potassium 
EDTA coated tubes (1.6 mg EDTA/ml blood, Sarstedt, Germany). All samples 
were kept on ice and later centrifuged at 3000 rpm for 15 min at +4 °C. Blood 
plasma was transferred to Eppendorf tubes for CORT determination and stored 
at -20 °C until further analysis. CORT was measured using a commercially 
available radioimmunoassay (RIA) kit containing 125iodine labelled CORT; 5 
µl of plasma were sufficient to carry out CORT measurement. Sensitivity of the 
assay was 0.125 µg/dl, inter- and intraassay variation was less than 10 and 5%, 
respectively (MP Biomedicals Inc., CA, USA). Vials were counted for 2 min in 
a gamma-scintillation counter (Packard Minaxi Gamma counter, Series 5000). 
 
2.2.2.8. BDNF measurement. BDNF evaluation was carried out with an 
enzyme-linked immunosorbent assay kits (Emaxtm ImmunoAssay System 
number G6891, by Promega, Madison, Wisconsin, USA) following the 
instructions provided by the manufacturer. Following sacrifice brains were 
quickly removed and the frontal cortex, hippocampus, hypothalamus, striatum 
and midbrain were dissected out and immediately stored at -80 °C until used. 
Brain tissues were homogenised in a lysis buffer prepared according to the kit 
instructions and centrifuged at 8500 rpm, and the supernatant was used for 
BDNF analyses. Briefly, BDNF standard and brain samples were distributed in 
96-well immunoplates precoated with monoclonal antimouse BDNF antibody 
(100 µl/well) and incubated for 2 h at room temperature. After washing plates 
were incubated with an anti-human BDNF antibody for 2 h at room 
temperature. The plates were washed again and then incubated with an anti-IgY 
horseradish peroxidase (HRP) for 1 h at room temperature. 
Tetramethylbenzidine (TMB)/peroxidase substrate solution was added to the 
wells to produce colorimetric reaction measured at 450 nm with a microplate 
reader (Dynatech MR 5000, Dynatech Laboratories, Chantilly, Virginia, USA). 
BDNF concentrations were determined from the regression line for the BDNF 
standard incubated under similar conditions in each assay. The sensitivity of the 
assay was about 15 pg/mg of BDNF, and the cross-reactivity with other related 
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neurotrophic factors (NGF, NT-3, and NT-4) is considered nil (Aloe et al., 
1999). 
 
2.2.2.9. Statistical analysis. Data were analysed using parametric analysis of 
variance (ANOVA) with ‘‘social condition’’ as between-subjects factor and 
‘‘time blocks’’ and ‘‘zone’’ as within-subject repeated measures, when 
appropriate (Sucrose Preference Test, Open Field, Elevated Plus Maze, Forced 
Swim Test, Social Interaction Test, CORT assessment and BDNF). Post hoc 
comparisons were performed using the Tukey’s test. In analysing data on social 
investigation (Social Interaction Test), this test was used in the absence of 
significant ANOVA effects according to the indications given by Wilcox 
(Wilcox, 1987). Statistical analysis was performed using Statview II (Abacus 
Concepts, CA, USA). Data are expressed as mean + SEM. A significance level 
of 0.05 was chosen. 
 
 
2.3. RESULTS 
 
2.3.1. Sucrose Preference Test - SPT 
Social condition affected the preference for a sucrose solution both in the SG 
and SS groups but not in SD mice (main effect of the social condition: F(2,41) = 
253.791; p < 0.0001, post hoc SD vs. SG and SS p < 0.01; SG vs. SS p < 0.05). 
The three groups showed the same basal preference for the sucrose solution 
which did not decrease in the SD group. After the first week the SG group 
developed a strong anhedonic profile which did not change from day 7 to 21. 
By contrast, the SS group developed anhedonia only during the last week of the 
stress procedure (day 21) (interaction between social condition and days: 
F(6,123) = 10.561; p < 0.0001, post hoc comparisons: SD vs. SG and SS p < 
0.01 on days 7, 14 and 21; SG vs. SS p < 0.01 on days 7 and 14; see Fig. 1). 
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Figure 1. Assessment of anhedonia in Sucrose Preference Test. Anhedonia increased over time 
in the social group (SG) and social stress (SS) conditions only. Results are presented as mean ± 
S.E.M. (social deprivation - SD, n = 12; SG and SS, n = 16), **p < 0.01 SD vs. SG and SS (days 
7, 14 and 21), #p < 0.01 SG vs. SS (days 7 and 14). 
 
 
2.3.2. Open Field - OF 
All subjects spent significantly more time in the peripheral part of the arena 
(main effect of the zone: F(1,21) = 202.673; p < 0.0001), this was particularly 
evident for the SD group (interaction between zone and social condition: 
F(2,21) = 9.093; p = 0.0006, post hoc SD vs. SG and SS p < 0.05 (Fig. 2A). 
Locomotor activity overall did not differ among groups (main effect of the 
social condition: F(2,21) = 0.042; p = 0.9585) and decreased for all subjects 
from tb 1 to 3 and increased again during tb 4, i.e. when a novel object was 
introduced in the arena (effect of time: F(3,63) = 10.416; p < 0.0001, post hoc tb 
1 vs. tb 2 and 3 p < 0.05; mean ± standard error: 40.2 ± 2.5; 36.1 ± 2.5; 34.7 ± 
2.7; 37.5 ± 2.6, respectively for tb 1, 2, 3 and 4). The SD group performed more 
rearing than the other groups (effect of the social condition: F(2,21) = 12.112; 
9.204; p < 0.0001; p = 0.0006, respectively for frequency and duration, post hoc 
SD vs. SG and SS p < 0.01) and this behaviour persisted over time during the 
test (interaction between tb and social condition: F(6,63) = 3.750; 2.274; p = 
0.0020; 0.0416, respectively for frequency and duration, post hoc SD vs. SG 
and SS tb 2, 3 and 4 p < 0.05; mean ± standard error: 51.2 ± 5.2; 65.4 ± 5.3; 
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60.7 ± 5.2; 36.8 ± 4.2, for the SD group for each tb respectively; 38.5 ± 3.4; 
42.3 ± 5.8: 34.5 ± 5.7; 14.1 ± 2.9, for the SG group for each tb respectively; 
34.9 ± 4.9; 31.4 ± 5.6; 32.4 ± 7.2; 20.3 ± 4.5, for SS group for each tb 
respectively). Overall, SD mice also showed a higher self-grooming frequency 
(effect of social condition: (F(2,21) = 4.857; p = 0.0134, post hoc SD vs. SG 
and SS p < 0.05), while the duration of this behaviour was not significant 
(F(2,21) = 2.340; p = 0.1105). 
 
2.3.3. Elevated Plus Maze - EPM 
All subjects spent more time in the closed arms of the maze (effect of the zone: 
F(1,21) = 36.952; p < 0.0001, post hoc closed arms vs. open arms p < 0.01), 
however this behaviour was particularly evident for the SD group (interaction 
between zone and social condition: F(2,21) = 4.463; p = 0.0185, post hoc SD vs. 
SG and SS p < 0.05, see Fig. 2B) that was characterised by a decreased 
locomotion (effect of social condition: F(2,21) = 6.125; p = 0.0051, post hoc SD 
vs. SG and SS p < 0.05), a higher frequency and duration of rearing (F(2,21) = 
3.873; 3.436; p = 0.0300; 0.0431, post hoc SD vs. SS p < 0.05, respectively for 
frequency and duration) and by a shorter latency and higher frequency of SAP 
(effect of social condition: F(2,21) = 3.355; 4.337; p = 0.0461; 0.0205, 
respectively for latency and frequency, post hoc SD vs. SG p < 0.05, for 
latency; SD vs. SG and SS p < 0.05, for frequency). In addition, SD together 
with the SS group, also showed a higher frequency and duration of self-
grooming (effect of social condition: F(2,21) = 4.694; 3.134; p = 0.0154; 
0.0556, post hoc SD and SS vs. SG p < 0.05, respectively for frequency and 
duration). 
 
2.3.4. Forced Swim Test - FST 
SD mice were overall characterised by a higher floating duration (effect of 
social condition: F(2,21) = 4.014;p = 0.0334, post hoc SD vs. SS p < 0.01, see 
Fig. 2C) associated to a lower struggling frequency (effect of social condition: 
(F(2,21) = 4.461; p = 0.0243, post hoc SD vs. SG p < 0.05). No difference was 
found among the three groups as for floating frequency (F(2,21) = 2.659; p = 
0.935), struggling duration (F(2,21) = 0.717; p = 0.4996) and frequency and 
duration of swimming (effect of social condition: F(2,21) = 2.106; 1.665; p = 
0.1468; 0.2131, respectively for frequency and duration).  
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Figure 2. Emotional and depression-like behaviours. Socially deprived (SD) mice were 
characterised by higher emotional responsiveness towards a novel environment as well as by 
increased anxiety since they spent more time respectively in the periphery of the Open Field arena 
(A) and in the closed arms of the Elevated Plus Maze (B). In addition, socially deprived mice 
showed the longest floating duration in the Forced Swim Test indicating a depression-like 
behavioural profile (C). Data shown are mean + S.E.M. (n = 8 for each experimental group). *p < 
0.05, **p < 0.01. 
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2.3.5. Social Interaction Test - SIT 
Despite the prolonged social deprivation (3 weeks) SD mice did not show any 
signs of aggressiveness while were characterised by a higher frequency and 
duration of social investigation (main effect of social condition: F(2,21) = 
3.755; 3.206; p = 0.0403; 0.0510, respectively for frequency and duration, post 
hoc SD vs. SG p < 0.05, both for frequency and duration, Fig. 3A) and spent a 
lower amount of time exploring the environment when compared to both SG 
and SS (effect of social condition on duration: F(2,21) = 6.467; p = 0.0065, post 
hoc p < 0.05, see Fig. 3B). Frequency of environmental exploration did not 
differ among the social conditions (F(2,21) = 1.075; p = 0.3594). SS mice were 
characterised by a lower frequency and duration of displacement behaviours 
(effect of social condition: F(2,21) = 8.592; 4.067; p = 0.0019; 0.0321, 
respectively for frequency and duration, post hoc SS vs. SD and SG p < 0.05, 
see Fig. 3C). 
No difference was found as for frequency and duration of affiliative 
behaviours (F(2,21) = 2.462; 1.890; p = 0.1095; 0.1759, respectively for 
frequency and duration). 
 
2.3.6. Corticosterone 
Basal CORT levels did not differ as a result of social condition (F(2,20) = 
0.442; p = 0.6487). The Social Interaction Test was effective in inducing the 
activation of the HPA axis in all the social conditions (effect of repeated 
measures: F(1,20) = 295.963; p < 0.0001, post hoc basal vs. stress p < 0.01), 
however CORT levels showed a higher increase in the SD group as a result of 
the social challenge (interaction between social condition and repeated 
measures: F(2,20) = 5.569; p = 0.0120, post hoc SD vs. SG p < 0.05 and SD vs. 
SS p < 0.01, Fig. 4A). 
 
2.3.7. Adrenals/body weight ratio 
Despite no difference in body weight among groups (F(2,21) = 0.385; p = 
0.6849), SD mice showed the highest values for adrenals/body weight ratio 
(F(2,21) = 7.103; p = 0.0044, post hoc SD vs. SG and SS p < 0.05, Fig. 4B). 
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Figure 3. Social anxiety. Results from the Social Interaction Test allowed a fine discrimination 
of the effects produced by chronic exposure to the different social contexts on social behaviour. 
Socially deprived (SD) mice spent more time investigating an unknown conspecific partner (A) 
than the new environment (duration of environmental exploration) (B). The social stress (SS) 
group spent less time in displacement behaviours than socially deprived and social group (SG) 
mice (C). Data show mean + S.E.M. (n = 8 for each experimental group). *p < 0.05.  
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Figure 4. Neuroendocrine activation following a social challenge. Although all subjects 
showed an activation of the HPA axis following the social challenge, socially deprived (SD) mice 
were characterised by a greater increase in corticosterone levels. In the inset the difference 
between basal and stress corticosterone levels (delta) (A). (SD and social group - SG, n = 8; SS, n 
= 7). In addition, the social deprivation group showed the highest ratio adrenal/body weight, 
suggesting a chronic stress-induced hypertrophy of the glands (B). Data show mean + S.E.M. (n = 
8 for each experimental group). *p < 0.05, **p < 0.01.  
 
 
2.3.8. BDNF 
Social condition was able to affect BDNF levels as measured in the frontal 
cortex, hippocampus, hypothalamus and midbrain (F(2,21) = 16.091; 12.667; 
12.764; 4.937; p = 0.0001; 0.0002; 0.0002; 0.0175, respectively for each area, 
see Fig. 5A-D). In particular the SD group was characterised always by lower 
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levels of this neurotrophin (post hoc SD vs. SG p < 0.05, for frontal cortex and 
hippocampus; SD vs. SG and SS p < 0.05, for hypothalamus and midbrain). SD 
mice were also characterised by a tendency to reduced BDNF levels in the 
striatum when compared to SG subjects (effect of social condition: F(2,21) = 
2.822; p = 0.0821). No difference was found among social conditions when 
adrenals levels of BDNF were analysed (F(2,21) = 0.942; p = 0.4056). 
 
 
 
 
 
Figure 5. Brain levels of BDNF. The social deprivation (SD) group was characterised by lower 
BDNF levels when compared only to the social group (SG) in the frontal cortex (A) and 
hippocampus (B); by contrast, post hoc  comparisons showed decreased BDNF levels in the 
hypothalamus (C) and midbrain (D) of SD mice when compared to both the group-housing 
conditions (SS and SG). Data show mean + S.E.M. (n = 8 for each experimental group). *p < 
0.05. 
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2.4 DISCUSSION 
Data from this study show that social deprivation, rather than social stress, leads 
to increased anxiety and depressive-like behaviours, accompanied by higher 
levels of corticosterone and reduced brain BDNF levels, all traits indicative of a 
disrupted emotional state. The results here reported also indicate that mice 
exposed to different social housing conditions use different behavioural 
strategies to cope with external challenges. 
When emotional behaviours were assessed, SD mice were indeed 
characterised by the most anxious phenotype, compared to SG and SS mice, as 
they spent more time in the periphery and showed a higher self-grooming 
frequency in the Open Field. As for the Elevated Plus Maze test, SD mice spent 
more time in the closed arms of the maze and were characterised by reduced 
locomotor activity and by a lower latency and higher frequency of stretched-
attend posture, a behaviour indicative of risk assessment. In addition, in the 
Forced Swim Test, SD subjects showed the highest floating duration and the 
lowest struggling frequency, commonly interpreted as measures of depressive-
like behaviour (Porsolt et al., 1977). 
In agreement with these behavioural data, when we investigated the effects 
of a social challenge on HPA axis activity, we found SD mice to be 
characterised by the highest CORT levels confirming an increased emotional 
profile in response to social stimuli (Gavrilovic and Dronjak, 2005). This result 
finds further support in data showing a higher adrenal/body weight ratio in SD 
subjects, a measure which is often associated with a hyperactive HPA axis 
(Ulrich-Lai et al., 2006). Worth noticing, adrenal enlargement, in association 
with increased glucocorticoids levels, have been found in many patients 
suffering from major depression (Rubin et al., 1987; Nemeroff et al., 1992). 
Data from the Social Interaction Test confirm and enlarge the profile 
previously described. In addition, observations from this test allow a fine 
discrimination of the effects produced by chronic exposure to different social 
contexts on the social behaviour of the two group-housed conditions (SG and 
SS), so far characterised by similar behavioural (Open Field and Elevated Plus 
Maze) and neuroendocrine (CORT levels) profiles. In fact, although SG and SS 
groups reacted similarly to the environmental novelty (clean cage), SS mice 
were characterised by a lower arousal (displacement behaviours) than the SG 
and by an overall social profile intermediate between SG and SD subjects. 
Socially deprived mice, in fact, showed a greater social alertness, possibly due 
to the prolonged deprivation, as suggested by the association between increased 
exploration of the unknown conspecific and the high amount of displacement 
behaviours (digging and self-grooming). By contrast, it is possible to 
hypothesise that SS mice, which were exposed to a highly variable and 
unpredictable social context, were better prepared than SG and SD to cope with 
a social challenge (Pardon et al., 2004). These data also seem to suggest that for 
laboratory rodents, changes in an established social structure, at least as 
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assessed in the C57BL/6J strain, which is characterised by relatively low 
aggressiveness, might represent a form of social enrichment acting as boredom 
breaking, rather than a source of stress (Siegfried et al., 1981; Jones and Brain, 
1987; Parmigiani et al., 1999). 
A growing body of evidence shows that stress decreases the expression of 
BDNF, a neurotrophin involved in the neuronal plasticity of brain structures 
underlying mood circuitry, contributing to the atrophy of these areas, and that 
antidepressant treatment reverses or blocks these effects (Duman and 
Monteggia, 2006; Castren et al., 2007).  
Our data show that social deprivation lowers BDNF in a number of limbic 
regions, including the hippocampus and frontal cortex in line with previous data 
indicating lower BDNF levels as a result of chronic stress (Tsankova et al., 
2006). The hypothalamus, in particular, was characterised by the largest 
difference in BDNF levels between socially deprived and grouphoused mice. 
This piece of data is in agreement with previous reports suggesting a specific 
role of hypothalamic BDNF in regulating neuroendocrine responses to stress 
(Tapia-Arancibia et al., 2004). As for the midbrain, this area is central to 
antidepressant action as it is characterised by high levels of 5-HT, a 
neurotransmitter involved in mood disorders, which is directly related to BDNF 
function (Thoenen et al., 1991; Lindholm et al., 1994). In our study, disruption 
of the social structure was used as a chronic stressor capable to induce anxiety- 
and/or depressive-like symptoms as is often reported in stressprecipitated major 
depression (Cryan and Holmes, 2005; Nutt and Stein, 2006). At the end of the 
stressful procedure, SS mice developed a condition of anhedonia while SD mice 
did not change their preference for the 4% sucrose solution. Interestingly, the 
SG group showed a decrease in sucrose preference similar, and even stronger, to 
that observed in the SS group. On the days anhedonia was assessed (day 0 - 
following 1 week of social deprivation, 7, 14 and 21), SG and SS mice 
underwent an acute social deprivation, being exposed to single-housing 
condition for 5 h, in order to score individual sucrose consumption. By contrast, 
SD mice did not change their social condition. Several studies have suggested 
that social experiences are intrinsically valuable, even when there is no clear 
opportunity for the approaching individual to benefit (Panksepp and Lahvis, 
2007; Trezza et al., 2010). For instance, subordinate mice express a strong 
preference for contact with a familiar dominant as long as a barrier prevents 
fighting behaviour (Van Loo et al., 2001). By contrast, many studies report a 
higher response to stimuli associated with reward in isolated rodents (Jones et 
al., 1990; Consorti et al., 1992; Coudereau et al., 1999). In line with these data, 
our results show that only subjects which underwent the Sucrose Preference 
Test, following separation from the social group, developed anhedonia 
suggesting that an acute social deprivation (5 h) is able to affect this behaviour 
in mice (D’Andrea et al., 2010). These same considerations apply to the fact 
that, despite most of the studies assess baseline preference for sucrose 
consumption in individually housed mice, this could represent a bias and should 
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be compared with baseline preference in group-housed mice (see for example 
Haenisch et al., 2009). 
It is important to emphasise that anxiety and depression co-exist and that 
anxiety symptoms typically precedes depressive disorders (Ballenger, 1999; 
Ninan, 1999; Nutt and Stein, 2006). Thus, we cannot exclude that, with a longer 
social deprivation period, changes in anhedonia might ensue also in SD mice, 
while anxiety might become less evident. 
Taken together, our findings indicate that mice exposed to different social 
housing conditions use different behavioural strategies to cope with external 
challenges. In addition they suggest that chronic social deprivation — rather 
than social instability — might trigger the emergence of anxiety, depression- 
like behaviours and neuroendocrine activation in association to reduced central 
levels of BDNF, at least as assessed in C57BL/6J adult male mice. Social 
isolation and lack of social support have deleterious effects on health, being 
regarded as one of the most relevant causes of diseases in human and other 
mammalian species. Overall, our data are in line with previous findings 
suggesting social deprivation as valid model for isolation-induced 
psychopathologies in human beings (Bartolomucci et al., 2003). By contrast, 
mice living in social groups (SG and SS) displayed higher levels of neural 
plasticity markers, such as BDNF, underlying the pivotal role of a stimulating 
social context for the prevention of psychopathology and giving further support 
to the neurotrophi theory of depression (Wood and Rebec, 2009; Cirulli et al., 
2010a). 
Finally, results from this study indicate that anhedonia is a complex 
behavioural trait, which can be influenced by a number of variables, including 
the social context. Indeed, since social experiences are able to shape the 
sensitivity to rewards, a note of caution has to be raised when using the sucrose 
preference protocols used in many animal models of depression.  
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ABSTRACT 
A growing body of evidence suggests that psychological stress is a major risk 
factor for psychiatric disorders. The basic mechanisms are still under 
investigation but involve changes in neuroendocrine-immune interactions, 
ultimately affecting brain plasticity. In this study we characterised central and 
peripheral effects of different stressors, applied for different time lengths in 
adult male C57BL/6J mice. We compared the effects of repeated (7 vs. 21 days) 
restraint stress (RS) and chronic disruption of social hierarchy (SS) on 
neuroendocrine (corticosterone) and immune function (cytokines and splenic 
apoptosis) and on a marker of brain plasticity (Brain-derived Neurotrophic 
Factor - BDNF -). Neuroendocrine activation did not differ between SS and 
control subjects, by contrast, the RS group showed a strong neuroendocrine 
response characterised by a specific time-dependent profile. Immune function 
and hippocampal BDNF levels were inversely related to hypothalamic-pituitary-
adrenal axis activation. These data show a fine modulation of the crosstalk 
between central and peripheral pathways of adaptation and plasticity and 
suggest that the length of stress exposure is crucial to determine its final 
outcome on health or disease. 
 
Keywords: Stress; HPA axis; Cytokines; Apoptosis; BDNF; Brain plasticity; 
Animal model; Mice. 
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3.1. INTRODUCTION 
Stressful events are well known risk factors that can promote neurochemical 
changes ultimately involved in the pathophysiology of psychiatric disorders 
such as major depression (Kendler et al., 1999; de Kloet et al., 2007; Cirulli et 
al., 2009). Any change of the internal or external milieu may represent a source 
of stress triggering a complex and coordinated set of physiological responses 
involving (among others) the activation of the hypothalamus-pituitary-adrenal 
(HPA) axis (McEwen, 2000; Eskandari and Sternberg, 2002; McEwen, 2004). 
Although adaptive on the short run, prolonged exposure to glucocorticoids 
hormones (GC) secreted following stress, may exhaust the capacity of an 
organism to cope with further stressors and, given the catabolic nature of these 
adrenal glucocorticoids, lead to an impairment in brain plasticity (McEwen, 
2004, 2008; Cirulli and Alleva, 2009).  
Stress begins in the brain with the perception and interpretation of the 
stressful event and affects the brain itself as well as the rest of the body through 
plastic changes, leading to adaptation. The connection between central stress 
response pathways and peripheral targets involves the alteration of a number of 
neurochemical and/or inflammatory factors that ultimately affect neuronal 
functioning and/or survival (Tapia-Arancibia et al., 2004; Cirulli and Alleva, 
2009). One of the most representative players implicated in these events is the 
neurotrophin Brain Derived Neurotrophic factor (BDNF), which is involved in 
synaptic and morphological plasticity of the brain both during development 
(with maximal levels during times of neuronal growth, differentiation and 
synaptogenesis) as well as at adulthood (Thoenen, 1995; Cirulli et al., 2010; 
Naert et al., 2011; Griesbach et al., 2012). High levels of this neurotrophin are 
found in the hippocampus, a brain region expressing also high levels of 
receptors for GC (GR) and playing a main role in the negative feedback 
regulation of the HPA axis, a pathway often disinhibited in depressed subjects 
(Sapolsky, 2001). A growing body of evidence shows that chronic stress 
decreases the expression of BDNF contributing to neuronal atrophy in the 
hippocampus and that antidepressant treatment reverses or blocks these effects, 
restoring brain plasticity (Tapia-Arancibia et al., 2004; Duman and Monteggia, 
2006; Castren et al., 2007; Cirulli and Alleva, 2009).  
By being able to directly affect HPA axis activity (Tapia-Arancibia et al., 
2004; Jeanneteau et al., 2012) and being produced by cells outside the nervous 
system (including immune cells, adipocytes, endocrine and endothelial cells) 
BDNF has a key position in integrating neural, immune and endocrine 
responses to stress (Aloe et al., 1986; Nockher and Renz, 2005; Cirulli and 
Alleva, 2009). Indeed, the central nervous system and the immune system are 
known to be engaged in an intense bidirectional crosstalk which can be affected 
by stress and which involves multiple mediators, including cytokines and 
growth factors (Hayley et al., 2005). As an example, the immune signalling 
cytokines, particularly the pro-inflammatory ones such as interleukin-6 (IL-6) or 
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tumor necrosis factor-alpha (TNF-α) are elevated following stress exposure and 
can thwart brain plasticity eliciting depressive symptoms, which are amenable 
to antidepressant treatment (Hayley et al., 2005). However, the directionality of 
the effects of stress is still a matter of intense investigation: for instance, GC 
released in response to stress can act both enhancing and inhibiting immune 
responses and by decreasing or increasing levels of neurotrophins (Barbany and 
Persson, 1992; Smith et al., 1995; Marmigere et al., 2003; Dhabhar, 2009). Such 
opposite effects might coexist in the light of the fact that, during stress, multiple 
interacting mediators are activated in a nonlinear network influencing different 
systems and functions (McEwen and Gianaros, 2010). Factors such as the 
duration (acute vs. chronic) of stress as well as the time of exposure to GC, 
relative to the activation and time course of the immune response might 
differently impact on health outcome (Dhabhar, 2009). Progress in 
understanding the pathophysiology of stress would greatly benefit from further 
preclinical studies incorporating both the permissive as well as the inhibitory 
role of GC in immune-endocrine interactions and mimic conditions experienced 
in everyday life (McEwen et al., 1997) 
Restraint stress (RS) and the chronic disruption of the social hierarchy 
(SS) are two of the most widely used experimental paradigms that can induce 
stress in mice. The first relies on a combination of psychological and physical 
stimuli and is considered a reliable model of severe stress in humans (Singh et 
al., 1999; Chiba et al., 2012); the latter represents a comprehensive and 
ethologically relevant paradigm inducing chronic stress and leading to anxiety 
and/or depressive-like symptoms as is often reported in stress-precipitated 
major depression (Cryan and Holmes, 2005; Nutt and Stein, 2006; Berry et al., 
2012).Thus, the main aim of the present study was to characterise central and 
peripheral effects of different stressors, applied for different time lengths on 
neuroendocrine and immune responses in adult male C57BL/6J mice. 
Specifically, we compared the effects of repeated (7 vs. 21 days) RS and SS on 
neuroendocrine (circulating corticosterone) and immune (circulating cytokines 
and splenic apoptosis) function and on a marker of brain plasticity 
(hippocampal BDNF) in order to identify a specific neuroendocrine profile in 
response to a selective type of stress. 
 
 
3.2. MATERIALS AND METHODS 
 
3.2.1. Animals 
Experimental subjects were adult male C57BL/6J mice purchased from a 
commercial breeder (Charles River, Calco, Italy). Upon arrival all animals were 
group-housed in the same room provided by air conditioning (temperature 21 ± 
1°C, relative humidity 60 ± 10%), in transparent Plexiglas cages (29 cm x 12 
cm x 14 cm), under a reversed 12/12 h light/dark cycle with lights off from 
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0800 to 2000 h. Pellet food (standard diet Altromin-R, Rieper, Italy) and tap 
water were continuously available. All stressors were administered randomly 
throughout the active phase of the day. A Social Interaction Test was used as a 
challenge to assess HPA axis response following the social stress procedure and 
took place between 1700-2000 h, i.e. during the corticosterone (CORT) 
circadian trough. All subjects were sacrificed at the end of the stress procedure. 
Animal handling and experimental procedures were performed in accordance 
with the EC guidelines (EC Council Directive 86/609 1987) and with the Italian 
legislation on animal experimentation (Decreto L.vo 116/92). 
 
3.2.2. Experimental Procedures 
3.2.2.1. Experiment I: effects of restraint stress on neuroendocrine and immune 
responses. Experimental subjects were 15 mice divided into three groups: 7 
days restraint stress (RS7, n=5); 21 days restraint stress (RS21, n=5) and 
unhandled controls (CTRL, 5 subjects left undisturbed in their home cage). All 
subjects were group-housed with subjects undergoing the same treatment 
condition. The restraint procedure consisted in removing subjects from their 
home cage and putting each of them in a conical 50 ml falcon tube, provided 
with holes for breathing, on a laboratory bench under dim light for 3 
consecutive hrs/day. The stress was administered each day at random times in 
order to prevent habituation to the procedure. Animals from the RS21 were used 
to assess stress-related changes in CORT levels so to have repeated measures 
for each subject during days 1, 7 and 21. On these days the procedure was 
administered at a fixed times in order to take into account circadian rhythm, i.e. 
from 1700-2000. Blood samples were collected by tail nick at 0 (basal) and 180 
min from the onset of stress (i.e. at 2000). At the end of stress all mice (CTRL, 
RS7 and RS21) were sacrificed, trunk blood was collected to assess levels of 
the pro-inflammatory cytokines Interleukin 6 (IL-6) and Tumor Necrosis 
Factor-alpha (TNF-), and of the anti-inflammatory cytokine Interleukin 10 
(IL-10), (Frick et al., 2008; Frick et al., 2009). Brains and spleen were dissected 
out in order to assess respectively hippocampal BDNF levels and lymphocyte 
apoptosis. 
 
3.2.2.2. Experiment II: effects of social stress on neuroendocrine and immune 
responses. Experimental subjects were 48 adult male mice divided into three 
groups: 7 days social stress (SS7, n=16), 21 days social stress (SS21, n=16) and 
controls (CTRL, 16 subjects group-housed). All mice undergoing the SS 
procedure were ear-marked and housed into 4 cages (4 mice/cage) and social 
structure was disrupted twice a week for one or three weeks by replacing one 
mouse with a novel unfamiliar selected randomly from another cage (Avitsur et 
al., 2003; Avitsur et al., 2006). Sawdust was replaced at the same time in all 
cages. Control mice were also ear-marked and housed in stable groups of 4 
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mice/cage. Cages were cleaned and sawdust replaced twice a week mimicking 
the handling procedure of the SS groups (Berry et al., 2012).  
The activity of the HPA axis was assessed in response to a 20 minutes acute 
stress (Social Interaction Test) and blood samples for CORT evaluation were 
collected from 8 subjects per group (CTRL, SS7, SS21) right before (basal) and 
30 min following the end of stress. Briefly, the night before the Social 
Interaction Test all subjects were individually housed to stimulate social 
interactions (Terranova et al., 1993; Cirulli et al., 1996; Panksepp et al., 2007). 
On the day of test, mice were placed in a novel cage, identical to the holding 
cage, ideally subdivided in three equal parts, with an unfamiliar conspecific of 
the same strain, weight and sex that had been previously isolated (standard 
opponent). Standard opponents were marked with a yellow, scentless and 
nontoxic paint (Berry et al., 2012). 
At the end of the test mice that did not undergo the Social Interaction test (5 
mice for each group, randomly chosen) were sacrificed, trunk blood was 
collected to assess also levels of IL-6, TNF-a and IL-10 (Frick et al., 2008; 
Frick et al., 2009). Brains and spleen were dissected out, in order to assess 
respectively hippocampal BDNF levels and lymphocyte apoptosis. 
 
3.2.2.3. Radioimmunoassay for corticosterone determination – RIA. Blood 
samples (100 µl, approximate volume) were collected individually in potassium 
EDTA coated tubes (1.6 mg EDTA/ml blood, Sarstedt, Germany). All samples 
were kept on ice and later centrifuged at 3000 rpm for 15 min at +4°C. Blood 
plasma was transferred to Eppendorf tubes for CORT determination and stored 
at -20°C until further analysis. CORT was measured using a commercially 
available radioimmunoassay (RIA) kit containing 125Iodine-labeled CORT; 5 
µl of plasma were sufficient to carry out CORT measurement. Sensitivity of the 
assay was 0.125 mg/dl, inter- and intra-assay variation was less than 10 and 5%, 
respectively (MP Biomedicals Inc., CA, USA). Vials were counted for 2 min in 
a gamma-scintillation counter (Packard Minaxi Gamma counter, Series 5000). 
 
3.2.2.4. BDNF measurement. BDNF evaluation was carried out with an 
enzyme-linked immunosorbent assay kit (BDNF Emax® ImmunoAssay System 
number G7610, Promega, Madison, Wisconsin, USA) following the instructions 
provided by the manufacturer. Following sacrifice brains were quickly removed 
and the hippocampus was dissected out and immediately stored at -80 °C until 
used. Brain tissues were homogenized in a lysis buffer and centrifuged at 14000 
rpm, and the supernatant was used for BDNF analyses. Briefly, BDNF standard 
and brain samples were distributed in 96-well immunoplates pre-coated with 
monoclonal anti-mouse BDNF antibody (100 mµ/well) and incubated for 2 h at 
room temperature. After washing plates were incubated with an anti-human 
BDNF antibody for 2 h at room temperature. The plates were washed again and 
then incubated with an anti-IgY horseradish peroxidase (HRP) for 1 h at room 
temperature. Tetramethylbenzidine (TMB)/peroxidase substrate solution was 
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added to the wells to produce colorimetric reaction measured at 450 nm with a 
microplate reader (Dynatech MR 5000, Dynatech Laboratories, Chantilly, 
Virginia, USA). BDNF concentrations were determined from the regression line 
for the BDNF standard incubated under similar conditions in each assay. The 
sensitivity of the assay was about 15 pg/mg of BDNF, and the cross-reactivity 
with other related neurotrophic factors (NGF, NT-3, and NT-4) is considered nil 
(Aloe et al., 1999). 
 
3.2.2.5. Cytokines determination. Quantitative evaluation of TNF-α, IL-6 and 
IL-10 in sera from trunk blood of stressed and control mice was determined by 
ELISA kits (R&D Systems, Inc. Minneapolis, USA) according to the 
manufacturer’s instructions. Briefly, standards, controls and sera were placed 
into the wells and incubated 2 h at room temperature. After washing 5 times, the 
enzyme-linked polyclonal antibody specific for mouse cytokines was added to 
the wells and then, after washing, the substrate solution was added. The enzyme 
reaction was read at 450nm (correction wavelength set at 570nm). The samples 
values were read off the standard value. 
 
3.2.2.6. Splenocytes apoptosis. Spleens were gently removed and suspended in 
ice–cold culture RPMI-1640 medium (GIBCO BRL, Grand Island, NY). 
Splenocytes were isolated from mice spleen by flushing 5 ml of RPMI-1640 
medium into spleen by needle and syringe. Cells were then centrifugated at 
1200 rpm in order to remove cellular debris. Cells were resuspended in 
supplemented RPMI 1640 and counted on a hemocytometer in trypan blue to 
ensure viability. Average viability was >90%. Splenocytes were then cultured in 
RPMI-1640 medium with 10% FBS (Euroclone, Pero, Italy), 2mM glutamine 
(Sigma, St Louis, MO) and 50μg/ml gentamycin (Sigma). Apoptosis was 
measured after 1h of culture. Apoptosis was quantified using FITC-conjugated 
annexin V (AV) and propidium iodide (PI) apoptosis detection kit (Marine 
Biological Laboratory, Woods Hole, MA) according to the manufacturer’s 
protocol. Reported data are referred to AV-positive apoptotic cells. AV binds to 
phosphatidylserine which is exposed at the outer surface of the cell membrane 
already at early stages of apoptosis and remains so during the subsequent 
process of apoptosis. By defining apoptotic cells as those cells staining with 
AV, irrespective of PI staining, we were able to detect early (AV+/PI- cells) as 
well as late (AV+/PI+ cells) apoptotic cells. In this study we analyzed 
specifically “early apoptosis” in which the nuclear changes are observed first, in 
contrast to the changes seen in the later stages of apoptosis and then in the 
necrosis, which usually begin with cell membrane damage (Wyllie et al., 1980; 
Perandones et al., 1993). Acquisition was performed on a FACSCalibur 
cytometer (BD Immunocytometry Systems) and 50.000 events per sample were 
run. Data were analyzed using the Cell Quest Pro (BD Immunocytometry 
Systems) software.  
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3.2.2.7. Statistical analysis. Data were analyzed using parametric analysis of 
variance (ANOVA) with ‘‘condition’’ (control and stress) as between-subjects 
factor (BDNF, cytokines, apoptosis, CORT) and “day” (1, 7, 21) and ‘‘time” (0 
and 180) as within-subject repeated measures (CORT assessment only for the 
restraint stress). Post hoc comparisons were performed using the Tukey’s test. 
Statistical analysis was performed using Statview II (Abacus Concepts, CA, 
USA). Data are expressed as mean + SEM. A significance level of 0.05 was 
chosen. 
 
 
3.3. RESULTS 
 
3.3.1. Experiment I - Restraint stress 
3.3.1.1. Corticosterone. Restraint stress was effective in challenging the HPA 
axis. In fact, RS subjects showed overall higher CORT levels (main effect of 
condition: F(1,8) = 17.917, P = 0.0029) compared to controls, particularly 180 
minutes from the onset of stress (interaction between condition and time: F(1,8) 
= 12.022, P = 0.0085). Moreover, a blunted HPA axis response characterised 
RS subjects on day 7 (main effect of days F(1,8) = 3.618 P = 0.0505; see Fig. 1 
A). 
 
 
 
Figure 1. Effect of restraint stress on CORT secretion in mice. All subjects undergoing RS 
showed a reduced response of the HPA axis on day 7 (A). Effect of social stress on CORT 
secretion in mice. The response to an acute challenge (represented by the Social Interaction Test) 
was effective in inducing an increase in CORT secretion in all groups, with no differences in 
relation to social stress exposure (B). Results are presented as mean + S.E.M. *P < 0.05. 
 
 
3.3.1.2. BDNF. BDNF evaluation was performed on 4 mice in each group since 
values from some subjects (1 subject for each group) were found to be outliers 
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and were therefore discarded from the analysis (Grubbs’ test performed by 
GraphPad Software).  
A time-dependent effect of RS was found for hippocampal BDNF levels (see 
Fig. 2). In particular, post hoc comparisons show a decrease in BDNF levels 
following 21 days of RS compared to RS7 (main effect of condition F(2,9) = 
4.164, P = 0.0500). The latter group did not differ from the CTRL subjects. 
However, it is worth noticing that the lack of difference between these two 
groups might be related to a reduced power of the statistical test (0.574) 
suggesting that this result suffers from a low number of experimental subjects 
(only 4 animals per experimental group) possibly masking other significant 
trends (RS7 vs CTRL).  
 
 
 
Figure 2. Effects of restraint stress on hippocampal BDNF levels. BDNF levels were 
decreased following a chronic 21 days restraint procedure compared to 7 days of repeated 
restraint. Data shown are mean + S.E.M. *P < 0.05. 
 
 
3.3.1.3. Cytokine production. Following 7 days of restraint stress a tendency to 
increase was observed for levels of IL-6 (F(2,12) = 3.480; P = 0.0643, Fig. 3 
A). This trend reached statistical significance when assessing TNF-α (main 
effect of condition: F(2,12) = 5.558; P = 0.0196, Fig. 3 B) that returned to basal 
levels after 21 days. By contrast, IL-10 increased only after 21 days of restraint 
(main effect of treatment: F(2,12) = 5.345; P = 0.0219, Fig. 3 C). 
 
3.3.1.4. Splenocytes apoptosis. Splenocytes apoptosis slightly decreased after 21 
days of restraint (main effect of condition: F(2,12) = 8.597; P = 0.0048, post 
hoc RS 7 days vs RS 21 days P < 0.01; see Fig. 3 D). No difference was found 
between CTRL and RS7.  
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Figure 3. Effect of RS and SS on the immune system response. Restraint stress procedure. 
Following 7 days of restraint stress the pro-inflammatory cytokine TNF-α increases (B) while the 
increase in IL-6 during days 7 and 21 just missed statistical significance (A); by contrast the anti-
inflammatory cytokine IL-10 increased following 21 days (C). The percentage of apoptotic 
splenocytes was found to be decreased following 21 days of stress (D). Social stress procedure. 
Levels of IL-10 were increased already after 7 days of the SS procedure (F). Splenocytes 
apoptosis was increased after 7 days of SS and decreased following 21 days (G). No difference is 
evident as for levels of IL-6 (E). Results are presented as mean + S.E.M.** P < 0.01, * P < 0.05 
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3.3.2. Experiment II - Social stress - 
3.3.2.1. Corticosterone. The Social Interaction Test was effective in inducing 
the activation of the HPA axis in all groups, regardless of their stress history 
(effect of social challenge: F(1,29) = 153,515; P < 0.0001, Fig. 1 B).  
 
3.3.2.2. BDNF. Social stress, per se, did not affect hippocampal BDNF levels 
(no main effect of condition: F(2,12) = 2.015 P = 0.1759, data not shown).  
 
3.3.2.3. Cytokine production. Social condition did not affect significantly the 
production of IL-6, even if a slight increase after 7 days of social stress was 
observed, (effect of condition: F(2,12) = 3.075 P = 0.0835, see Fig. 3 E). By 
contrast, serum levels of IL-10 increased after 7 days of the social stress 
procedure (main effect of condition: F(2,12) = 13.217 P = 0.0009, see Fig. 3 F). 
Differences in serum TNF levels between control and social stressed mice 
appeared undetectable (data not shown). 
 
3.3.2.4. Splenocytes apoptosis. Splenocytes apoptosis increased after 7 days of 
social stress and decreased following 21 days (main effect of treatment: F(2,12) 
= 47.932; P < 0.0001, see Fig. 3 G).  
 
 
3.4. DISCUSSION 
Data from this study show that chronic RS is a powerful stressor eliciting strong 
neuroendocrine and immune responses and that brief vs. prolonged exposure to 
this stress result in a differential activation of these systems in mice. In addition, 
we were able to identify a specific neuroendocrine-immune profile associated to 
specific changes in hippocampal BDNF levels. Results suggest a fine 
modulation of the crosstalk between central and peripheral pathways of 
adaptation and plasticity and that the length of stress exposure is crucial to 
determine its final outcome on health or disease. 
Allostasis - or “stability through change” - is defined as any neural, 
neuroendocrine and immune activation leading to adaptation in the face of 
stressful challenges (McEwen, 2000). While in the short run activation of these 
systems is essential to the maintenance of homeostasis and survival yet, over 
longer time intervals, it imposes a cost - allostatic load - that can accelerate 
disease processes or participate to pathological changes associated, among 
others, to immunosuppression (McEwen, 2000). When we studied the 
characteristics of the diverse stressors applied for different lengths of times, we 
found that upon prolonged exposure to RS (21 days) an increase in the 
immunogenic/allostatic load was observed, mirrored by a peak in CORT levels 
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comparable to that observed on day 1. This was associated to a suppression of 
the immune system with decreased levels of the pro-inflammatory cytokine 
TNF-α and increased levels of the anti-inflammatory cytokine IL-10. In 
addition, a decrease in hippocampal BDNF levels was found, suggesting a 
reduction in the ability to cope with prolonged stress (brain plasticity).  
Analyzing more in detail the effects of RS, we found that, following 7 days 
of this procedure, CORT elevation was significantly lower than on the first 
stimulation (day1), suggesting an habituation of the system to the chronic 
procedure, as previously shown (Bhatnagar et al., 2002). This effect, which 
appears to be mediated by limbic regions (Cirulli and Alleva, 2009), is likely to 
have consequences for the functioning of a number of GC-sensitive systems, 
including the immune system. Indeed, reduced CORT levels could disinhibit 
immune function, leading to a pro-inflammatory response, as suggested by the 
increase in the levels of TNF-α.  
A number of evidence support the hypothesis that a moderate increase in 
the levels of pro-inflammatory cytokines, such as TNF- α might result in an 
overall ‘priming effect’ on the immune system, leading to better abilities to 
cope with further physiologic/stressful stimuli (Ehrke et al., 1998; Ehrke et al., 
2000; van Horssen et al., 2006; Dhabhar, 2009; Watters and O'Connor, 2011). 
Worth noticing, the response to stress observed does not only involve peripheral 
targets, but also extends to central mediators. In fact, after 7 days of RS, 
hippocampal BDNF protein levels showed a trend towards an increase, possibly 
reflecting a neuroprotective mechanism. By contrast, after 21 days of RS, 
BDNF levels were found to be decreased and this was associated to an 
augmented anti-inflammatory response by the immune system with increased 
IL-10 levels and a return of TNF-α to basal. It must be emphasized that while 
acute changes in BDNF levels might represent a coping response to stressful 
events, and thus being beneficial, prolonged exposure to stressors and increased 
allostatic load would lead to detrimental effects as reduced BDNF signalling in 
the adult brain may be involved in the pathophysiology of psychiatric disorders 
(Altar, 1999; Castren, 2005; Sen et al., 2008). 
A fine regulation of apoptosis might positively affect optimal immune 
function. This is achieved by maintaining lymphocyte homeostasis by a 
continuous removal of cells that have been activated once they have served their 
function. Therefore, inappropriate induction of such a mechanism could result 
in a variety of pathological effects such as autoimmune diseases, while the 
maintenance of physiologically regulated levels of apoptosis might exert a 
beneficial/protective effect (Avula et al., 2001). In this context, the observed 
decrease in apoptosis levels following 21 days of RS, suggests a long-term 
impairment of the immune system response. 
Compared to RS, SS resulted in an overall lower response of the HPA axis 
as well as of the immune system. Differences were both quantitative and 
qualitative. In particular, no change in TNF- α could be detected, while an 
earlier increase in IL-10 was observed compared to RS, suggesting an 
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anticipated anti-inflammatory reaction in response to this specific stressor. 
Differently from RS data, splenic apoptosis increased after 7 days of SS, 
suggesting that it might represent a reliable early stress-sensitive physiological 
marker. 
Taken together, data from this study clearly indicate a differential role of 
psychophysical vs. social and of brief vs. prolonged stress on neuroendocrine 
and immune function suggesting that the quality and the extent of the stress 
period are crucial in determining individual neuroendocrine-immune responses 
to external challenges. In addition, and more intriguingly, all these peripheral 
responses were associated to specific changes in hippocampal BDNF levels. We 
hypothesize that this neurotrophin might represent a key modulator of neuro-
immuno-endocrine pathways, playing a pivotal role in the 
orchestration/maintenance of the brain and peripheral plasticity leading to 
optimal coping strategies to stressful events (Cirulli and Alleva, 2009). Future 
studies should employ pharmacological challenges aimed at investigating such 
interactions. 
While this is a first attempt to mimic some of the qualitative and temporal 
features of “stress”, studies are ongoing to extend the range of mediators 
analyzed and the peripheral targets, to evaluate more extensively the role of 
acute vs. chronic stressors on neuroendocrine and immune function. In addition 
a thorough characterization of the specific changes occurring in brain plasticity 
in other regions involved in neuroendocrine-immune integration will help 
elucidating the mechanisms underlying the beneficial/pathological effects of 
stress increasing the translational value of these studies. 
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ABSTRACT 
Breast cancer is the second leading cause of cancer death and the most common 
carcinoma among women. A wealth of data has been so far collected to indicate 
that stressful conditions might accelerate tumor onset and progression although 
the mechanisms are hard to tackle. We tested the hypothesis that psychological 
stress might trigger a Brain-derived Neurotrophic Factor (BDNF) -
neuroendocrine cascade leading to cancer progression. To this aim, we assessed 
the effects of a prolonged social isolation (6 months) in a transgenic mouse 
model of breast cancer susceptibility (MMTVNeuTg). In addition, by the time 
mice started developing tumors (about 5 months), they were exposed to a 
further stressful challenge (restraint stress). Data indicate that in MMTVNeuTg 
mice social isolation accelerates disease onset, earlier detection of lumps in the 
mammary glands and tumor development being accompanied by significant 
histological modifications in the mammary fat pad. A higher rate of splenocyte 
apoptosis was also found, suggesting an impairment of immune function. In 
general, effects were magnified in those subjects experiencing both isolation 
and restraint stress and were accompanied by low BDNF expression in the 
hypothalamus as well as increased leptin and decreased adiponectin expression 
in peripheral fat tissue, suggesting the involvement of a 
neuroendocrine/metabolic cascade in tumor progression. From a behavioural 
point of view, MMTVNeuTg mice were characterised by greater anhedonia, a 
behavioural trait indicative of a depressive-like state, which was exacerbated by 
restraint stress. Overall, data indicate that social isolation stress plays a pivotal 
role in promoting disease onset and progression in this animal model and that 
BDNF and metabolic signals are mechanistically involved in translating 
stressful experiences into disease susceptibility. 
 
Keywords: Breast cancer; Stress; BDNF; Leptin; Adiponectin; Cytokines; Fat; 
Depression 
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4.1. INTRODUCTION 
Breast cancer is one of the most common cancers among women with greater 
than 1.300.000 cases and 450.000 deaths each year worldwide. Although most 
cancer research is mainly focused on molecular and cellular interactions, there 
is now clear evidence that psychological factors can influence disease 
progression. Stressful conditions, in particular, are a recognized risk factor for 
cancer in the clinic and are linked to breast cancer aggressiveness in animal 
models (Hermes et al., 2009; Volden et al., 2013). Lack of social support, a 
known psychosocial stressor, has been associated with pain, fatigue, lethargy 
and higher inflammation among cancer patients (Gagliardi et al., 2009; Hughes 
et al., 2014), while in mouse models of cancer, exposure to social isolation 
alters tumor and spleen macrophage populations and potentiates tumor growth 
and metastasis (Hermes et al., 2009; Williams et al., 2009; Madden et al., 2013; 
Volden et al., 2013). It is important to consider that 15-50% of breast cancer 
patients meet diagnostic criteria for anxiety and depression (Burgess et al., 
2005; Gagliardi et al., 2009; Lutgendorf and Sood, 2011) and that the tumor 
itself can produce depressive symptoms, through the expression of cytokines 
and growth factors, generating a positive feedback loop between coping style 
and cancer progression (Sephton et al., 2009).  
Stress begins in the brain with the perception and elaboration of an external 
event as stressful and affects the brain itself, as well as the rest of the body 
through plastic changes, leading to adaptation. The connection between central 
stress response pathways and peripheral targets involves the activation of a 
number of neurochemical and/or inflammatory mediators that ultimately can 
affect cell function and/or survival including cytokines and growth factors 
(Hayley et al., 2005; Cirulli and Alleva, 2009; Moreno-Smith et al., 2011; 
Capoccia et al., 2013). Depressed metastatic breast cancer patients are often 
characterised by blunted cortisol awakening responses reflecting a physiologic 
profile associated with chronic stress (Sephton et al., 2009). These endocrine 
changes have the potential to override the immune defense or act directly on the 
tumor microenvironment, affecting cancer progression. Evidence in animal 
models suggests that prolonged exposure to stress – with a persistent activation 
of the hypothalamic-pituitary-adrenal axis and the consequent suppressed 
activity of the immune system, mediated by glucocorticoid (GCs) hormones, 
can render subjects more susceptible to disease, including neoplastic processes 
(Cavigelli et al., 2008).  
In addition to classic neuroendocrine factors, BDNF has been recently 
recognized as playing an important role in integrating neural, immune and 
endocrine responses to stress (Cirulli and Alleva, 2009; Capoccia et al., 2013). 
This neurotrophin is implicated in the pathophysiology of the nervous system, 
including the etiopathogenesis of depression, while in the periphery it regulates 
metabolic responses to stress (Cirulli and Alleva, 2009) and has been recently 
involved in tumor development and progression (Cirulli and Alleva, 2009; Yang 
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et al., 2012; Liu et al., 2014). Indeed, recent data indicate that increased 
expression of hypothalamic BDNF, resulting from environmental enrichment, 
activates sympathetic innervation of white adipose tissue, leading to important 
changes in circulating levels of adipokines, ultimately resulting in tumor 
suppression (Cao et al., 2010; Cao and During, 2012; Liu et al., 2014). The 
crosstalk between brain and peripheral targets could also be mediated by other 
stress-responsive genes, also playing a role in metabolic pathways, such as 
neuropeptide Y (NPY), agouti-related peptide (AgRP), serum and 
glucocorticoid-regulated protein kinase 1 (SGK1) and insulin receptor (InsR) 
(Hou et al., 2011; Anacker et al., 2013; Baver et al., 2014).  
While the effects of environmental enrichment – and the role of BDNF – 
on tumor suppression have been previously documented (Cao et al., 2010; Cao 
and During, 2012), much less research has been dedicated to investigate 
whether an opposite condition, such as social isolation, might instead promote 
cancer progression. Social isolation has been previously shown as a relevant 
stressor capable to promote breast tumor growth in epidemiological studies 
(Gagliardi et al., 2009; Hughes et al., 2014) and it has been employed to 
examine potential long-lasting effects on behavioural and biological responses 
to stress in mice (Williams et al., 2009; Ma et al., 2011; Berry et al., 2012). 
However, none of these studies has taken into account the role of BDNF and of 
related metabolic signals in the effects of stress on tumor biology.  
In this paper we tested the effects of social isolation on tumor progression 
in a transgenic mouse model of breast cancer. The MMTVNeuTg mice 
specifically overexpress ErbB2 (Her2/Neu), a member of the ErbB family of 
receptor tyrosine kinases (RTKs), which is overexpressed in advanced breast 
cancers with an especially poor clinical prognosis (Slamon et al., 1987; Perou et 
al., 2000; Ursini-Siegel et al., 2007).  
The hypothesis underlying this work is that stress would act on the 
hypothalamus, activating neuroendocrine pathways, thwarting immune function 
and modifying the expression of genes involved in the response to stress, 
including BDNF, affecting the production of circulating cytokines and adipose 
tissue-derived adipokines, promoting tumor progression (Berry et al., 2012; 
Capoccia et al., 2013; Wosiski-Kuhn et al., 2014). Often an acute stressful event 
can be superimposed upon a long-term vulnerability. Thus we assessed whether 
a 21-day restraint stress procedure, experienced by the time tumor growth was 
well established, would worsen the effects of a long-term social isolation. 
Depressive symptoms often accompany breast cancer patients as a result from 
situational fear related to diagnosis and prognosis or may be directly related to 
the effects of the tumor and Lamkin and co-workers have recently shown an 
increase in endophenotypes of depression following tumor implantation 
(Lamkin et al., 2011). Thus a further aim of this study was to assess whether 
changes in tumor biology, resulting from stress exposure, would also be 
accompanied by an increase in endophenotypes of depression, previously 
validated in animal models, such as anhedonia. 
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4.2. MATERIALS AND METHODS 
 
4.2.1. Animals 
Experimental subjects were ErbB-2(Neu)TgMMTV-ErbB-2 (FVB background) 
and FVB mice purchased from The Jackson Laboratory (Bar Harbor, Maine, 
USA) via Charles River (Calco, Italy). Upon arrival, all animals were housed in 
the same room provided by air conditioning (temperature 21 ± 1°C, relative 
humidity 60 ± 10%), in transparent Plexiglas cages (29 cm × 12 cm × 14 cm), 
under a reversed 12/12 h light/dark cycle with lights off from 0800 to 2000 h. 
Pellet food (standard diet Altromin-R, Rieper, Italy) and tap water were 
continuously available. More in detail, MMTVNeuTg subjects develop 
hyperplasia at 5 months and focal adenocarcinoma and lung metastases at 7 
months. Mice were used to fulfill the criteria of: i) late latency of tumor 
occurrence to allow chronic stress treatment and ii) extensively characterised 
tumor model with respect to morphological and histological features. Subjects 
in this experiment were all females, 36 MMTVNeuTg and 40 FVB (wild type –
WT-, control group). Half of them were socially isolated at weaning to model 
long-term stress; to test the effect of a further stressful challenge experienced at 
adulthood half of them underwent restraint stress (RS) by the time they started 
developing tumors (5 months) (n = 9 MMTVNeuTg group-housed control; n = 
10 MMTVNeuTg group-housed RS; n = 8 MMTVNeuTg isolated control; n = 9 
MMTVNeuTg isolated RS; n = 10 FVB group-housed control; n = 10 FVB 
group-housed RS; n = 10 FVB isolated control; n = 10 FVB isolated RS). At the 
end of stress procedures, all mice were sacrificed, hypothalamus and adipose 
tissue were dissected out in order to assess, respectively, BDNF, SgK1, AgRP, 
InsR, Npy and leptin and adiponectin gene expression. Lymphocyte apoptosis 
was assessed in the spleen. In order to assess “basal” physiological responses, 
before tumor development, a dedicated batch of 2-month-old females was 
divided into unhandled controls (n = 10 MMTVNeuTg; n = 4 FVB) and acute 
RS (n = 8 MMTVNeuTg; n = 7 FVB) undergoing a single stressful challenge 
for 3 hours. Unhandled controls were sacrificed one week following acclimation 
in the animal facility while, on the same day, RS subjects were sacrificed 1 hr 
after the end of the stress procedure. Hypothalamic BDNF gene expression, 
adipose tissue leptin and adiponectin gene expression and splenocytes apoptosis 
were assessed. 
Animal handling and experimental procedures were performed in accordance 
with the EC guidelines (Directive 86/609/EEC) and with the Italian legislation 
on animal experimentation (Decreto L.vo 116/92).  
 
4.2.2. Experimental procedures 
4.2.2.1. Assessment of breast lumps and tumor masses. We assessed the effects 
of a prolonged social isolation (6 months) starting at weaning in MMTVNeuTg 
mice. In order to test the effect of further stressful challenges experienced at 
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adulthood, experimental subjects underwent restraint stress by the time they 
started developing tumors (5 months). We performed the assessment of lumps 
and tumor masses in the ten mammary glands of each mouse through palpation 
performed once a week from the age of 16 weeks until week 26 (Fig. 1). Breast 
lumps and tumor masses were then calculated as follows:  
Tot n. breast lumps/tumor masses for each group
n. mice for each group x 10
X 10(                                )                               
 
 
To control for the handling procedure due to palpation, all mice were palpated, 
including FVB. 
 
4.2.2.2. Restraint stress. Each mouse was introduced in a conical 50mL falcon 
tube, provided with holes for breathing, adjusted on a laboratory bench with 
tape to prevent rolling. The stress was administered each day for 3 consecutive 
hrs/day at random times in order to prevent habituation to the procedure. Blood 
samples were collected by tail nick on days 1 and 21 at 0 (basal) 180 and 240 
min from the onset of stress to assess changes in CORT levels.  
For the acute procedure in 2-month-old females HPA axis activity was 
evaluated only on day 1 before and immediately after 3 hours of contention. On 
these days the procedure was always administered at a fixed times in order to 
take into account circadian rhythm, that is, from 1700 to 2000.  
 
4.2.2.3. Estrous cycle monitoring. Since natural fluctuations in sex hormones 
have enormous influences on neuroendocrine function and tumor growth, the 
oestral cycle of the experimental subjects was assessed. In particular, at the end 
of RS (day 1 for acute challenge and days 1 and 21 for chronic procedure) 
vaginal secretions were collected, transferred on a glass slide and a trace of 
methylene blue was added to increase contrast and bring out the nuclei. Oestrus 
cycle was determined by examining the proportion and morphology of 
leukocytes and epithelial cells present in the vaginal smear of mice: proestrus 
(80–100% intact, live epithelial cells), estrus (100% cornified epithelia), 
metestrus (50% cornified epithelia and 50% leukocytes), or diestrus (80–100% 
leukocytes).  
 
4.2.2.4. Saccharin consumption – Anhedonia. Mice have strong preference for 
sweet solutions such as those containing sucrose or saccharin and the intake of 
these compounds are considered to be due to their hedonic properties (Cryan 
and Holmes, 2005; Branchi et al., 2013). Eighteen-week-old MMTVNeuTg 
mice were habituated to a saccharin solution for three days. After this period, 
experimental subjects underwent 10 days of familiarization and each cage was 
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provided with two bottles, one containing fresh tap-water and one containing 
0.1% of saccharin solution. Bottles were daily weighed in order to monitor 
liquid consumption and switched to balance the effect of side preference in 
drinking behaviour, which has been reported to be of importance for the correct 
evaluation of saccharin preference (Strekalova et al., 2004; Branchi et al., 
2013). Following the establishment of the preference for saccharin solution, half 
of the experimental subjects underwent chronic restraint stress (21 days) and the 
bottles were daily weighed in order to monitor liquid consumption. For isolated 
subjects saccharin preference was evaluated through the single mouse 
consumption, while for group housed, the average of the mice was considered. 
Saccharin preference was then calculated as follows: 
Saccharin solution intake x 100
Water intake + Saccharin solution intake
% saccharin preference  =
 
Saccharin consumption was derived from bottles’ weight. Body weight of 
experimental subjects was registered before and after familiarization, and on 
days 7, 14 and 21 from restraint stress. 
 
4.2.2.5. Radioimmunoassay (RIA) for corticosterone determination. Blood 
samples (20 µl, approximate volume) were collected individually in potassium 
EDTA coated tubes (1.6 mg EDTA/ml blood, Sarstedt, Germany). All samples 
were kept on ice and later centrifuged at 3000 rpm for 15 min at +4 °C. Blood 
plasma was transferred to Eppendorf tubes for CORT determination and stored 
at -20 °C until further analysis. CORT was measured using a commercially 
available radioimmunoassay (RIA) kit containing 125iodine labelled CORT; 5 
µl of plasma were sufficient to carry out CORT measurement. Sensitivity of the 
assay was 0.125 mg/dl, inter- and intra-assay variation was less than 10 and 5%, 
respectively (MP Biomedicals Inc., CA, USA). Vials were counted for 2 min in 
a gamma-scintillation counter (Packard Minaxi Gamma counter, Series 5000).  
 
4.2.2.6. Quantitative real-time reverse transcription-PCR (RT-PCR). Total 
RNA was extracted from frozen hypotalamic and subcutaneous white adipose 
tissues with Trizol (Invitrogen, Carlsbad, CA) and the RNeasy Lipid Tissue 
Mini Kit (Qiagen, Hilden, Germany) following the manufacturer's instruction. 
Quantity and quality were assessed by Nanodrop ND-1000 spectrophotometer 
using OD260 for calculation of the concentration and the ratios 260/280 and 
260/230 for assessing the purity of the samples. After cDNA synthesis using 
Superscript III (Invitrogen), Real-time RT–PCR was performed by the TaqMan 
technology, using the ABI PRISM 7700 DNA Sequence Detection System 
(Applied Biosystems, Foster City, CA). TaqMan reactions were carried out in 
96-well plates using cDNA, TaqMan universal PCR mastermix, preoptimized, 
and preformulated TaqMan gene expressions assays including specific primers 
 86 
and fluorescent probes for mouse, and water to a final volume of 25μl according 
to the manufacturer's instructions. Commercial ready-to-use primers/probe 
mixes (Assays on Demand Products, Applied Biosystems) are listed: Adipoq 
#Mm00456425_m1; Lep #Mm00434759_m1; Insr #Mm01211875_m1; Bdnf # 
Mm 04230607_s1; Sgk1 #Mm 00441387_g1; Agrp #Mm 00475829_g1; Lepr 
#Mm 00440181_m1, Npy #Mm 03048253_m1; Eef2 #Mm 01171435_gh; 
GAPDH #Mm99999915_g1. Eef2 and GAPDH were used as the internal 
control for efficiency of RT-PCR and subsequent normalization for 
hypothalamus an adipose tissue respectively. The Δct values were used for 
statistical analysis.  
 
4.2.2.7. Splenocytes Apoptosis. Spleens were gently removed and suspended in 
ice-cold culture RPMI-1640 medium (GIBCO BRL, Grand Island, NY). 
Splenocytes were isolated from mice spleen by flushing 5mL of RPMI-1640 
medium into spleen by needle and syringe. Cells were then centrifugated at 
1200 rpm in order to remove cellular debris and treated as previously described 
(Capoccia et al. 2013). In this study, we analyzed specifically “early apoptosis” 
characterised by nuclear changes observed first, in contrast to the changes seen 
in the later stages of apoptosis and then in the necrosis, which usually begin 
with cell membrane damage (Wyllie et al., 1980; Perandones et al., 1993). 
Acquisition was performed on a FACSCalibur cytometer (BD 
Immunocytometry Systems) and 50.000 events per sample were run. Data were 
analyzed using the Cell Quest Pro (BD Immunocytometry Systems) software. 
 
4.2.2.8. Cytokines Determination. Trunk blood was collected individually in 
anticoagulant-free vials allowed to clot for 20 minutes at room temperature and 
then centrifuged at 3000 rpm for 15 min at +4 °C. Serum was then stored at -80 
°C until cytokines determination was carried out. Quantitative evaluation of 
TNF- , IL-6, and IL-10 in sera from trunk blood of stressed and control mice, 
was determined by ELISA kits (R&D Systems, Inc., Minneapolis, USA) 
according to the manufacturer’s instructions. Briefly, standards, controls, and 
sera were placed into the wells and incubated 2 h at room temperature. After 
washing 5 times, the enzyme-linked polyclonal antibody specific for mouse 
cytokines was added to the wells and then, after washing, the substrate solution 
was added. The enzyme reaction was read at 450nm (correction wavelength set 
at 570 nm). The samples values were read off the standard value. 
 
4.2.2.9. Histological analysis. The hematoxylin and eosin stain (H&E) was 
performed on Formalin Fixed Paraffin Embedded (FFPE) tissue sections from 
6-months-old subjects (n=5 for each experimental group). Slides (5µm thick) 
were deparaffinized, hydrated through graded alcohols and H&E staining was 
performed according to standard protocols.  
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4.2.2.10. Statistical Analysis. Data were analyzed using parametric analysis of 
variance (ANOVA) with “social condition” (group-housed and isolation) and 
“treatment” (control and restraint stress) as between-subjects factor (breast 
lumps, tumor masses, genes, apoptosis, CORT) and “day” (1, 7, 14 and 21) and 
“time course” (0, 180 and 240) as within-subject repeated measures (CORT 
assessment only for the restraint stress; breast lumps and tumor masses 
assessment, saccharin consumption and body weight). Since transgenic mice 
developed tumors at 6 months of age, we analyzed separately WT and 
transgenic mice for hypothalamic and adipose tissue gene expression and for 
cytokine levels. A linear multiple regression model was used to assess the effect 
of estrous cycle on corticosterone levels, with genotype (WT = 0; 
MMTVNeuTg = 1), social condition (group-housed = 0; isolation = 1), day (1, 
21), and estrous phase (estrous = 0; proestrous = 0-1, phase 1; post-estrous 
(diestrous + metaestrous) = 0-1, phase 2) as dependent variables and CORT 
level at different time course (0, 180 and 240) as independent variable. Post hoc 
comparisons were performed using the Tukey’s test. Statistical analysis was 
performed using Statview II (Abacus Concepts, CA, USA). Data are expressed 
as mean + SEM. A significance level of 0.05 was chosen.  
 
 
4.3. RESULTS 
 
4.3.1. Assessment of breast lumps and tumor masses 
Nineteen weeks of social isolation resulted in a greater number of breast lumps 
compared to group-housed controls (interaction between social condition and 
weeks of age F(4,136) = 5.266, p = 0.0006). This effect was magnified over 
time (main effect of social condition F(1,32) = 9.008, P = 0.0052; effect of 
weeks of age F(2,64) = 14.474, p < 0.0001) and when RS was superimposed 
upon isolation (interaction among RS and weeks of age F(2, 64) = 5.707, p = 
0.0052, Fig. 1A, upper panel). Social deprivation accelerated onset of breast 
cancer: at 20 weeks of age we found that 33% of the isolated mice had 
developed at least one tumor, while no group-housed subject did (main effect of 
social condition F(1, 34) = 3.845, p = 0.0581; interaction between social 
condition and weeks of age F(4, 136) = 3.845, p = 0.0054), although no 
difference in tumor masses was found between isolated and group-housed mice 
after 21 weeks of age, when restraint stress procedure was applied (no 
interaction among social condition, restraint stress and weeks of age F(2, 64) = 
0.387, p = 0.6807) (Fig. 1B, upper panel). No breast lumps were found in 
stressed FVB mice. 
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4.3.2. Histological analysis 
Histological examination of mammary glands in the transgenic mice indicated 
that prolonged exposure to social isolation induced white adipose tissue (WAT) 
“browning”, adipocytes being characterised by multilocular small lipid drops 
(Fig. 1C, panel d), compared to control FVB subjects, which, by contrast 
showed WAT made of cells showing a single (unilocular) large lipid drop (Fig. 
1C, panel a). The effect of social isolation was amplified by restraint stress, 
which was able to induce a milder response when imposed alone (Fig. 1C, 
panels e and c respectively). 
 
4.3.3. Hypothalamic gene expression in response to stress 
At 2 months of age, we tested hypothalamic BDNF gene expression in response 
to an acute restraint stress to test the system well before MMTVNeuTg subjects 
developed any tumor. At this age no difference in BDNF expression was found 
as a result of transgenosis and, as expected, expression of this neurotrophin was 
significantly reduced following stress, (main effect of acute restraint stress 
F(1,12) = 5.510, p = 0.0369, data not shown). When subjects were tested at 6 
months of age, a time when tumor progression becomes manifest, 
MMTVNeuTg mice were characterised by lower basal BDNF levels in the 
hypothalamus and were found to be hyporesponsive upon a stressful challenge 
(restraint stress) compared to wild types (interaction between genotype and 
restraint stress F(1,30) = 7.345, p = 0.0110).  
Interestingly, we found that both social isolation (main effect of social condition 
F(1,16) = 5.593, p = 0.0310) and restraint stress reduced hypothalamic BDNF 
expression (main effect of restraint stress F(1,16) = 7.532, p = 0.0144) in 
MMTVNeuTg subjects (Fig. 2A). At this age, gene expression for a number of 
genes involved in the response to stress (serum/glucocorticoid regulated kinase 
(SgK1), agouti related peptide (AgRP), Insulin receptor (InsR) and 
Neuropeptide Y (Npy) was measured. Regardless of genotype, prolonged social 
isolation decreased hypothalamic expression of these genes (main effect of 
social condition F(1,32) = 4.053; 7.728; p = 0.0526; 0.0090 respectively for 
AgRP and InsR). Following restraint stress these genes were activated, rather 
than suppressed, as in the case of BDNF (interaction between social condition 
and restraint stress F(1,32) = 85.640; 43.926; 34.110; 40.733, p < 0.0001 
respectively for SgK1, AgRP, InsR and Npy genes, suggesting a different 
regulatory mechanism (Fig. 2B).  
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Figure.1. Breast lumps (A) and tumor masses (B) in the MMTVNeuTg mice mammary 
gland assessed through palpation. Isolation stress increased breast lumps and promoted tumor 
onset. At 20 weeks of age we found that 33% of the isolated mice had developed at least one 
tumour, while no group-housed subject did. Data show mean + S.E.M. *p<0.05. (C) H&E 
staining of mammary glands sections. Brown adipocytes in WAT were found in MMTVNeuTg 
following chronic isolation (panel d) compared to FVB (panel a) and group housed MMTVNeuTg 
(panel b). The effect of social isolation was amplified by restraint stress (panel e), which was able 
to induce a milder response when imposed alone (panel c). All specimens are shown under 100-
fold magnification. The boxed areas are enlarged images with 200-fold magnification.  
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Figure 2. Gene expression in the hypothalamus of MMTVNeuTg mice through RT-PCR. 
Both social isolation and restraint stress reduced BDNF m-RNA levels (A). In addition, prolonged 
social isolation decreased expression of Sgk1, Agrp, InsR and NPY, while restraint stress 
activated these genes (B). Data show mean + S.E.M. (n = 5 for each experimental group). *p < 
0.05, **p < 0.01 main effect of the social condition, $p< 0.05, $$p< 0.01 main effect of stress. 
 
 
4.3.4. Gene expression in adipose tissue 
At 2 months of age, acute restraint stress decreased leptin gene expression 
(main effect of acute restraint stress F(1,12) = 67.330, p < 0.0001) in all 
subjects and adiponectin only in MMTVNeuTg mice (main effect of genotype 
F(1,12) = 10.308, p = 0.0075; interaction between genotype and acute restraint 
stress F(1,12) = 7.920, p = 0.0156, Fig. 3A). These responses changed 
drastically when transgenic mice developed tumor and chronic stressors were 
applied. More in detail, at 6 months of age, regardless of genotype, social 
isolation increased leptin gene expression in adipose tissue (main effect of 
social condition F(1,32) = 15.361, p = 0.0004, data not shown). Interestingly, 
the same procedure affected the adiponectin gene expression differently in 
MMTVNeuTg and FVB mice, isolated transgenic mice showing lower levels of 
the adipokine when restraint stress was superimposed (main effect of genotype 
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F(1,32) = 7.016, p = 0.0124; interaction between social condition and restraint 
stress F(1,32) = 24.496, p < 0.0001). 
We found that leptin and adiponectin had different roles in mediating stress 
reactions in MMTVNeuTg mice. More in detail, leptin expression was 
increased significantly by social isolation but not by the stressful challenge 
(main effect of social condition F(1,16) = 5.262, p = 0.0357). However, 
adiponectin expression in fat increased following 21 days of restraint while this 
same stress was able to revert the effect of social isolation, reporting levels of 
this chemokine to those of controls (interaction between social condition and 
restraint stress F(1,16) = 41.511, p < 0.0001, Fig. 3B). Interestingly, social 
isolation decreased InsR expression (main effect of social condition F(1,16) = 
7.264, p = 0.0159) possibly promoting insulin resistance (Fig. 3B).  
 
 
Figure 3. Gene expression in the adipose tissue through RT-PCR. (A) Acute restraint stress 
decreased leptin m-RNA levels in all subjects and adiponectin only in MMTVNeuTg mice (2 
months of age). *p < 0.05, main effect of RS, $p< 0.05 main effect of genotype. (B) Gene 
expression in MMTVNeuTg mice. Six month-old isolated transgenic mice were characterised by 
increased expression of leptin and decreased expression of adiponectin (after restraint exposure) 
and InsR. *p < 0.05, **p < 0.01 main effect of social condition, $p< 0.05 main effect of RS. Data 
show mean + S.E.M. (n = 5 for each experimental group). 
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4.3.5. Neuroendocrine response 
HPA axis activity was found to differ in MMTVNeuTg females at 2-months of 
age, at a time when these subjects have not developed tumors yet. At this age, 
the transgenic animals showed increased CORT levels after 180 min of restraint 
compared to WT, with evidence of negative feedback after 240 min, at a time 
when CORT levels in WT subjects were still rising (interaction between 
genotype and time course F(1,28) = 19.922, p < 0.0001, Fig. 4). This profile 
was no longer evident at 6 months of age. MMTVNeuTg group-housed subjects 
showed lower HPA axis activation on the first day of restraint stress, an effect 
reverted by social isolation (interaction between genotype and social isolation 
F(1,35) = 9.340, p = 0.0043) (Fig. 4).  
The response of the HPA axis to chronic restraint stress was affected by social 
isolation and genetic background, MMTVNeuTg mice were more resilient to 
changes in corticosterone levels, suggesting an inability to mount a coping 
response to stressful challenges after 21 days of restraint, compared to FVB 
mice (interaction among genotype, social condition and days F(2,66) = 5.084, p 
= 0.0309, data not shown). 
 
 
Figure 4. Neuroendocrine response. At 2-months of age MMTVNeuTg females showed 
increased CORT levels after 180 min of restraint compared to WT, with evidence of negative 
feedback after 240 min. At 6-months of age social isolation increases corticosterone levels in the 
transgenic mice after the stressful challenge. Data show mean + S.E.M. (n = 8 group 2 months-
old; n = 10 group 6 months-old; n = 8 isolated 6 months-old). *p < 0.05 main effect of genotype , 
$p< 0.05 main effect of the time course: 180 vs. both 0 and 240. 
 
 
4.3.6. Estrous cycle 
Mammary glands change during estrous cycle and there is evidence linking the 
increase in estrogen exposure throughout life with an increase in breast cancer 
risk (Velie et al., 2005; MacLennan et al., 2011). We thus tested estrous cycle to 
discern whether effects of stress on tumor progression might depend upon 
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changes in sex hormones. An interaction between tumor susceptibility and 
stress exposure was found, transgenic mice moving to the proestrous phase 
(MMTVNeuTg group housed: 10% on day 1 and 40% on day 21 of restraint; 
MMTVNeuTg isolated: 44.4% on day 1 and 100% on day 21 of restraint) thus 
indicating that sex hormones are not likely to mediate the effects on stress on 
tumor progression. By contrast, isolated WT mice were found more often more 
in estrous phase compared to other subjects (50% and 40% on day 1 and 21 of 
restraint stress respectively). In addition, no correlation between stress and sex 
hormones was found (regression coefficient = 33.614; 80.482; 40.294, SE = 
20.318; 71.040; 53.724, p = 0.1027; 0.2612; 0.4558 respectively at 0, 180 and 
240 minutes from the chronic restraint procedure on day 21). 
 
4.3.7. Cytokine Production 
MMTVNeuTg and WT subjects did not differ for the overall levels of cytokines 
(main effect of genotype F(1,33) = 0.448; F(1,54) = 1.189; F(1,53) = 0.642, p = 
0.5078; 0.2803; 0.4267 respectively forIL-6, IL-10 and TNF-α ). However, 
serum cytokine determination is complex and cytokines resulted undetectable 
for some mice (above all wild type subjects). In the MMTVNeuTg mice, TNF-α 
decreased upon isolation after stressful challenge exposure, while IL-6 
production increased (interaction between social condition and restraint stress 
F(1,20) = 5.420; F(1,17) = 4.696; p = 0.0305; 0.0447 respectively for TNF-α 
(Fig. 5A) and IL-6 (Fig. 5B)), while the anti-inflammatory cytokine IL-10 
increased after prolonged social isolation (main effect of social condition 
F(1,26) = 4.679, p = 0.0399, Fig. 5C). 
 
4.3.8. Splenocytes Apoptosis 
The immune system response was evaluated also analyzing splenic lymphocytes 
apoptosis, a marker of cellular injury and reduced immune functions. At 2-
months of age higher levels of splenocyte apoptosis were found in 
MMTVNeuTg mice compared to WT (main effect of genotype F(1,15) = 4.993, 
p = 0.0411) suggesting that tumor susceptibility was already reflected in a 
reduced immune response. Moreover this profile was inverted after an acute 
challenge (interaction between genotype and treatment F(1,15) = 20.654, p = 
0.0004, data not shown). The impairment of immune response in transgenic 
mice was still present at adulthood, MMTVNeuTg mice showing greater 
splenocyte apoptosis compared to WT subjects, an effect amplified by social 
isolation and restraint stress exposure (main effect of genotype F(1,67) = 
150.700, p < 0.0001; interaction among genotype, social condition and restraint 
stress F(1,67) = 13.033, p = 0.0006, Fig. 5D). Interestingly, regardless of 
genotype, stressful conditions increased the percentage of Annexin V positive 
cells (main effect of social condition F(1,67) = 41.423, p < 0.0001; main effect 
of restraint stress F(1,67) = 24.292, p < 0.0001). 
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Figure 5. Immune response in MMTVNeuTg mice. Isolated transgenic mice were characterised 
by increased levels of IL-10 (C). After restraint stress IL-6 levels were increased (B), while levels 
of TNF-α were decreased (A). In addition, MMTVNeuTg mice showed a higher rate of 
splenocyte apoptosis after stressful exposure (D). Data show mean + S.E.M. (n = 5 group control, 
6 group restraint stress, 5 isolated control, 5 isolated restraint stress for IL-6; n = 4 group control, 
5 group restraint stress, 6 isolated control, 6 isolated restraint stress for TNF-α; n = 9 group 
control, 7 group restraint stress, 7 isolated control, 7 isolated restraint stress for IL-10; n = 9 group 
control, 10 group restraint stress, 8 isolated control, 8 isolated restraint stress for splenocyte 
apoptosis). *p < 0.05, $p< 0.05, main effect of the social condition. 
 
 
4.3.9. Anhedonia and body weight 
MMTVNeuTg mice were characterised by an anhedonic profile, already during 
the familiarization phase, showing lower levels of saccharin consumption 
compared to WT (main effect of genotype F(1,72) = 4.067, p = 0.0474). This 
effect was also present during the restraint stress exposure (main effect of 
genotype F(1,68) = 24.111, p < 0.0001; interaction between restraint stress and 
repeated measure F(2,136) = 5.486, p = 0.0051; interaction among genotype, 
social condition and repeated measure F(2,136) = 2.927, p = 0.0569, 
Fig.6).Worth noticing, all isolated mice exhibited a greater preference for the 
saccharin solution compared to group-housed (main effect of social condition 
F(1,72) = 23.870, p < 0.0001) confirming that prolonged social isolation 
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influences response to stimuli associated with reward as previously shown 
(Berry et al., 2012). 
Body weight was influenced by genotype and stress, MMTVNeuTg and isolated 
subjects showing lower body weight compared to FVB group-housed mice 
during familiarization phase (main effect of genotype F(1,72) = 17.090, p < 
0.0001; main effect of social condition F(1,72) = 12.465, p = 0.0007; interaction 
between genotype and social condition F(1,72) = 5.391) (data not shown). 
These data were confirmed over time, MMTVNeuTg group-housed mice 
showing a significant decrease of body weight after restraint stress procedure 
(main effect of restraint stress F(1,68) = 36.468, p < 0.0001; interaction among 
genotype, social condition, restraint stress and time course F(2,136) = 3.485, p = 
0.0334, data not shown). 
 
 
 
Figure 6. Anhedonia. MMTVNeuTg mice were characterised by an anhedonic profile showing 
lower levels of saccharine consumption compared to WT and this effect was amplified by 
stressful exposure. Data show mean + S.E.M. (n = 10 FVB for each experimental group; n = 9 
MMTVNeu Tg group control, 10 group restraint stress, 8 isolated control, 9 isolated restraint 
stress). *p < 0.05 WT isolated vs WT group housed, $p < 0.05 MMTVNeuTg group vs WT 
group, #p < 0.05 MMTVNeuTg isolated vs WT isolated. 
4.4. DISCUSSION 
Data from this study reveal that social isolation accelerates onset of breast 
cancer in MMTVNeuTg mice with earlier detection of lumps in the mammary 
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glands and earlier tumor development, accompanied by browning of the 
mammary fat pad, compared to controls. These effects were magnified in those 
subjects experiencing a further stress (restraint stress) and were accompanied by 
increased HPA axis activity, low levels of BDNF expression in the 
hypothalamus, increased cytokines levels, as well as increased expression of 
leptin and decreased expression of adiponectin in peripheral fat tissue. 
The MMTVNeuTg mouse model used was chosen for this study because of 
its late latency of tumor occurrence, which allows studying the effects of a 
chronic stress treatment, such as social isolation. Subjects were isolated starting 
at weaning and up to a time when mice started to develop tumors in the 
mammary glands. Our data indicate that already by week 19, social isolation 
was able to affect mammary glands structure, MMTVNeuTg isolated subjects 
being characterised by a greater number of breast lumps, compared to group-
housed controls. In addition, an early onset of breast tumors was found at 20 
weeks of age, isolated mice having developed, on average, at least one tumor by 
this time, compared to group-housed subjects, who developed none. The effect 
of social isolation on breast lumps was still present after 21 weeks of age and up 
to 23 weeks, although this was not paralleled by a significant increase in tumor 
masses. The histological analysis of mammary glands indicated that isolated 
transgenic mice display small, multilocular adipocytes that are reminiscent of 
brown adipose tissue (BAT). This kind of fat is exclusively detected in the 
mouse early in mammary gland development, particularly during stages of 
ductal growth, and is associated with the synthesis and secretion of angiogenic 
and growth factors, resulting in markedly increased vascular density and, 
therefore, involved in cancer development (Jones et al., 2011; Cao et al., 2014). 
Recently, it has been reported that a switch from white to brown fat is found in 
cancer-associated cachexia and is linked to greater tissue energy expenditure 
(Petruzzelli et al., 2014). The higher presence of BAT in stressed and isolated 
mice indicates that these subjects have a more metabolically active tissue, a 
process which is likely to fuel the tumor, and which could be at the base of the 
greater detection of breast lumps through palpation. It must be emphasized here 
that, given the peculiarity of the transgenic model, it is likely that a ceiling 
effect at some point occurs so that it is hard to detect significant differences in 
tumor number. Nonetheless, a more metabolically active tissue could lead to an 
earlier onset of cachexia in these animals, a hypothesis that will need to be 
tested with subsequent studies (Petruzzelli et al., 2014). 
These effects of social isolation are in agreement with previous reports 
indicating an increased effect of social isolation on mammary tumors (Williams 
et al., 2009; Volden et al., 2013). However, differently from these studies, 
which were mainly concentrated on the tumor microenvironment, we attempted 
to tackle the cascade of events starting with the hypothalamus - an area of the 
brain that is critical in the regulation of both energy balance and 
neuroendocrine-immune interaction through the HPA axis – assessing changes 
in the expression of genes known to be involved in the neuroendocrine response 
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to stress, and with demonstrated effects on cancer progression, such as BDNF 
(Cirulli and Alleva, 2009; Yang et al., 2012; Liu et al., 2014). The work of Cao 
and collaborators (Cao et al., 2010; Cao and During, 2012) has very effectively 
shown how the maintenance of high levels of this BDNF in the hypothalamus 
can be a preventive factor for tumor growth. Given the numerous data 
documenting a negative regulation of the BDNF gene by stress-induced changes 
in glucocorticoid hormones (Barbany and Persson, 1992) we hypothesized that 
a prolonged exposure to a social stressor might act as a risk factor for tumor 
onset and progression in this genetically modified mouse model. Our data 
indeed show low levels of hypothalamic BDNF expression as characterising 
isolated mice, thus supporting a role for this neurotrophin in the above-
described changes in the mammary glands tissue found in these mice. 
Accompanying changes in BDNF expression, we found decreased hypothalamic 
expression of a number of genes involved in the response to stress and in 
metabolic regulations (SgK1, AgRP, InsR and Npy), as expected given the role 
of the hypothalamus as a sensor of metabolic signals. Interestingly, when a 
further stress was applied for 21 days, we found that BDNF levels were still 
low, while the other stress-responsive genes were re-activated, suggesting a 
selective regulatory mechanism underlying BDNF transcriptional regulation.  
Hypothalamic BDNF plays an important role in stress adaptation 
ultimately affecting endocrine and metabolic responses. Recent data indicate 
that BDNF can affect sympathoneural innervation of peripheral fat tissue, 
maintaining an optimal level of adipokines production, ultimately influencing 
tumor growth. Thus, the decreased expression of this neurotrophin following 
chronic social stress, could affect this peripheral target, promoting the disease 
(Cirulli and Alleva, 2009; Cao and During, 2012). Leptin, mainly secreted by 
the adipose tissue exerts pro-angiogenic, pro-inflammatory, mitotic and anti-
apoptotic actions inducing breast cancer development (Grossmann and Cleary, 
2012; Khan et al., 2013). By contrast, adiponectin represses tumor proliferation 
in breast cancer cells, low blood concentrations of adiponectin being associated 
with high incidence and poor prognosis of breast cancer (Jarde et al., 2011). In 
this study, we found that isolated subjects showed increased leptin and 
decreased adiponectin gene expression in peripheral adipose tissue, both 
promoting tumor progression. Both leptin and adiponectin expression were 
increased by social isolation, but a further stressful challenge, was then able to 
reduce adiponectin levels, thus creating a permissive environment for tumor 
progression. The finding of higher levels of adiponectin gene expression 
characterising transgenic mice at two months of age, allows hypothesizing a 
protective role of this hormone in response to transgenosis.  
Adipokines have been linked to both inflammation (Kwon and Pessin, 
2013) and cancer progression (Grossmann and Cleary, 2012). At the same time, 
cytokines have been reported to be associated with breast cancer development 
(Nicolini et al., 2006) and we found that TNF-α decreased in isolated 
MMTVNeuTg mice after stressful challenge exposure, while IL-6 production 
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increased. These results are in line with the antitumor properties of TNF-α, 
which is a multifunctional cytokine, playing a key role in apoptosis and cell 
survival as well as in inflammation and immunity (van Horssen et al., 2006). 
Indeed, our data reveal that chronic social isolation affects the production of this 
cytokine, promoting disease. As for IL-6, there is some evidence that elevated 
serum levels of this cytokine are significant indicators of poor prognosis and 
favor tumor growth (Nakashima et al., 2000; Petruzzelli et al., 2014). In 
addition, also the immunosuppressive cytokine IL-10 increased after prolonged 
social isolation suggesting a response of the immune system aimed at restoring 
homeostasis following stress (Capoccia et al., 2013). Complementing these data 
is the greater splenocyte apoptosis in MMTVNeuTg mice, an effect amplified 
by social isolation and restraint stress exposure. Interestingly, we found 
increased levels of splenocyte apoptosis in transgenic subjects already at two 
months of age and this result might be related to the susceptibility of the mouse 
model.  
Thus overall, increased leptin and decreased adiponectin levels in the 
adipose tissue, together with increased levels of IL-6 could contribute to 
promote an insulin-resistant inflammatory state involved in the promotion and 
progression of cancer. Furthermore, increased levels of cytokines, such as IL-6, 
as well as increased NPY expression are also likely to contribute to promote 
depressive symptoms as it is has been previously shown that these are increased 
and correlate with depression severity in patients (Dantzer et al., 2008; Maes et 
al., 2014). Our data indicate increased expression of anhedonia in 
MMTVNeuTg mice (Lamkin et al., 2011) both in the familiarization phase and 
during the restraint stress exposure suggesting the potential role of a stressful 
challenge to precipitate depression symptoms.  
In summary, results from this study indicate that the macro-environment, 
here exemplified by lack of social interactions, can affect physiological 
responses and breast cancer onset and progression at multiple levels. In 
particular, social deprivation and stressful events can amplify the consequences 
of a genetic susceptibility accelerating and precipitating the disease, also 
through modifications of the mammary fat pad tissue. One important factor that 
deserves attention, and which has not been specifically tested in this study, is 
the role of the sympathetic nervous system in the regulations described, as beta 
blockers have been shown to reduce the effects of stress on tumor growth 
(Hasegawa and Saiki, 2002), sympathetic innervation of white adipose tissue 
being regulated by hypothalamic BDNF (Cao et al., 2010). Studies are currently 
in progress to add this piece to the puzzle. 
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5. GENERAL DISCUSSION 
Within a species, the ability to cope with environmental stressful challenges 
largely determines individual survival in their natural habitat. Coping with 
stress involves the activation of a number of physiological and behavioural 
responses that are functional to maintaining homeostasis. Since human and 
mouse physiology largely overlaps, at least as for the stress-system responses, 
murine models of stress are widely used, in a translational approach, to dissect 
out how physiological and behavioural responses can be finely modulated as a 
result of different stressful conditions. Indeed exposure to stressful events can 
be an important risk factor for a number of pathological conditions, including 
neoplasia, although the mechanisms underlying the ultimate outcome of stress 
are poorly understood. In fact, factors such as the duration (acute vs. chronic) of 
stressful events as well as the time of exposure to GC, relative to the activation 
and time course of the immune response, might differently impact health 
outcome and the directionality of these effects is still a matter of intense 
investigation.  
Thus the objective of the studies described in this thesis was to explore the 
relationship among brain activation and neuroendocrine and immune system 
changes in response to different environmental challenges. To this aim both 
central (BDNF levels) and peripheral (CORT, cytokines, splenic apoptosis, 
leptin and adiponectin levels) responses, as well as endophenotype of 
depression, were analyzed in wild type and transgenic mice following different 
stressors, applied for different time lengths. 
 
 
5.1. MAIN FINDINGS 
 
5.1.1. Social isolation promotes anxiety and depression-like behaviour 
In a first study we investigated the effect of housing conditions on the 
behavioural response. Since mice are social animals and live in social groups, 
both the disruption of social hierarchy as well as social isolation represent two 
ethologically relevant stressors.  
Chronic stress is a triggering factor for several psychiatric disorders. 
Interestingly, in rodents, social stress appears to be a good model to induce both 
anxiety and depression-like behaviours (Pothion et al., 2004; Mutlu et al., 2009) 
leading to reduced locomotor activity, reduced food and water intake and 
decreased responsiveness to reward stimuli (Griffiths et al., 1992), all 
behavioural changes resambling those observed in human clinical condition of 
depression. Our analyses on the behavioural characterisation shown in Chapter 
2 are in line with these studies and indicate a crucial role for social isolation as a 
relevant condition leading to increased anxiety and depressive-like behaviours, 
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accompanied by higher levels of CORT and reduced brain BDNF levels, all 
traits indicative of a disrupted emotional state.  
When emotional behaviours were assessed in the Open Field, isolated mice 
showed an anxious phenotype, spending more time in the periphery and 
showing a higher self-grooming frequency. As for the typical test capable to 
elicit anxiety, the Elevated Plus Maze test, the same experimental subjects spent 
more time in the “safe” closed arms of the maze and were characterised by 
reduced locomotor activity and by a lower latency and higher frequency of 
stretched-attend posture, a behaviour indicative of risk assessment. In addition, 
in the Forced Swim Test, isolated subjects showed the highest floating duration 
and the lowest struggling frequency, which are commonly interpreted as 
measures of depressive-like behaviour (Porsolt et al., 1977). However, in terms 
of anhedonic profile, isolated mice exhibited a greater preference for a sucrose 
solution compared to the other experimental groups. These data are in line with 
many studies reporting a higher response to stimuli associated with reward in 
isolated rodents (Jones et al., 1990; Consorti et al., 1992; Coudereau et al., 
1999). It must be taken into account that, in Chapter 2, group-housed mice 
were exposed to a single-housing condition for 5 h in order to score individual 
sucrose consumption. Several studies have shown that social experiences are 
intrinsically valuable, even when there is no clear opportunity for the 
approaching individual to benefit (Panksepp and Lahvis, 2007; Trezza et al., 
2010). Our results are in line with these data showing that only those subjects 
that were acutely (5 h) separated from the social group developed anhedonia 
(D'Andrea et al., 2010). Following this line of reasoning, we can deduce that 
individually housing mice leads to a change in sucrose preference which can 
override the effects of other treatments that could be superimposed on the same 
subject (Haenisch et al., 2009).  
In agreement with behavioural data, when we investigated the effects of a 
social challenge on HPA axis activity, we found isolated subjects to be 
characterised by the highest levels of CORT, adrenal/body weight ratio 
confirming an increased neuroendocrine and emotional profile in response to 
social stimuli (Gavrilovic and Dronjak, 2005; Ulrich-Lai et al., 2006). Worth 
noticing, adrenal enlargement, in association with increased glucocorticoids 
levels, has been found in many patients suffering from major depression (Rubin 
et al., 1987; Nemeroff et al., 1992). 
Interestingly, in our study anxiety and depression-like behaviours were 
related to reduced BDNF levels in limbic regions of isolated subjects, a result 
that confirms an association between neuroendocrine dysregulations, 
endophenotypes of depression and reduced neuroplasticity (Duman and 
Monteggia, 2006; Schule et al., 2006; Castren et al., 2007). Overall, these 
results represent further evidence that social isolation in mice have deleterious 
effects on health and can be used to model psychopathological condition 
induced or precipitated by isolation and lack of social support in human beings 
(Bartolomucci et al., 2003).  
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5.1.2. Nature and length of stress exposure are crucial to determine the 
final outcome on health or disease 
In the short run stressful experiences result into neuronal, neuroendocrine and 
immune activation which are necessary for adaptation (McEwen, 2000, 2007; 
Dhabhar, 2009). However, over longer time laps, stress can lead to a wide 
variety of behavioural, cognitive, physiological, and neuronal changes that can 
promote vulnerability to diseases (McEwen, 2000). In Chapter 3 we studied the 
characteristics of the diverse stressors applied for different lengths of times, and 
we found a fine modulation of the crosstalk between central and peripheral 
pathways of adaptation and plasticity, the length of stress exposure being crucial 
to determine its final outcome on health or disease. More in detail, upon 
prolonged exposure to restraint stress (21 days), an increase in the 
immunogenic/allostatic load was observed, mirrored by a peak in CORT levels 
comparable to that observed on the first day of stress (day 1, acute response). 
Interestingly, this response was associated to a suppression of the immune 
system with decreased levels of the proinflammatory cytokine TNF-   and 
increased levels of the anti-inflammatory cytokine IL-10. In addition, a decrease 
in hippocampal BDNF levels was found, suggesting a reduction in the ability to 
cope with prolonged stress (brain plasticity). By contrast, following 7 days of 
the same procedure, we found that CORT elevation was significantly lower than 
on the first stimulation (day 1) and this was associated to proinflammatory and 
coping responses, as suggested by the increase in the levels of TNF-  and in the 
central BDNF protein. Thus, our data clarify the mechanisms through which 
stress can differentially affect an organism, identifying a specific 
neuroendocrine-immune profile associated to specific changes in hippocampal 
BDNF levels. In particular, the central response after 7 days of restraint stress is 
likely to reflect a neuroprotective mechanism in response to HPA axis 
activation. By contrast, after 21 days of the same procedure, BDNF levels were 
decreased, an effect associated to an augmented anti-inflammatory response, as 
indicated by increased levels of IL-10. It must be emphasized that while acute 
changes in BDNF levels might represent a coping response to stressful events, 
and thus being beneficial, reduced BDNF signalling in response to prolonged 
exposure to stressors would have detrimental effects on brain plasticity (Altar, 
1999; Sen et al., 2008; Cirulli and Alleva, 2009).  
A fine regulation of apoptosis might positively affect optimal immune 
function. This is achieved by maintaining lymphocyte homeostasis through a 
continuous removal of cells that have been activated once they have served their 
function. Therefore, inappropriate induction of such a mechanism could result 
in a variety of pathological effects such as autoimmune diseases, while the 
maintenance of physiologically regulated levels of apoptosis might exert a 
beneficial/protective effect (Avula et al., 2001). In this context, the observed 
decrease in apoptosis levels following 21 days of restraint stress, suggests a 
long-term impairment of the immune system response. 
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In Chapter 3 we extended our analysis to investigate the effects of 
stressors of different nature. In particular, we studied two experimental 
paradigms that can induce stress in mice: chronic disruption of the social 
hierarchy and restraint stress. From a behavioural perspective, restraint stress 
may model a naturally occurring event in the life of wild mice. In nature, mice 
live in underground burrows that may collapse, leaving a mouse trapped. Forced 
restraint may imitate the collapse of a burrow, triggering a “programmed” 
response specific for these situations. An appropriate response probably is an 
attempt to escape by digging a way out. After several unsuccessful attempts to 
escape, a mouse might give up and remain in its place, immobile (Avitsur et al., 
2009). Social stress, by contrast, is based upon the highly territorial nature of 
rodents. An attacked mouse evaluates its opponent's strength and vigor based on 
its scent, behaviour, and size. Previous experiences in similar situations also 
would affect behaviour (Avitsur et al., 2009). These two stressors are especially 
different in that restraint stress is an uncontrollable and inescapable situation, 
while social stress allows some aspects of coping to be put in place, ultimately 
resulting in a milder stressor. 
In this study, compared to restraint, social stress resulted in an overall 
lower response of the HPA axis, as well as of the immune system. Differences 
were both quantitative and qualitative. In particular, no change in TNF-  could 
be detected, while an earlier increase in IL-10 was observed compared to 
psychophysical stress, suggesting an anticipated anti-inflammatory reaction in 
response to this specific stressor. Differently from restraint stress data, splenic 
apoptosis increased after 7 days of SS, suggesting that it might represent a 
reliable early stress-sensitive physiological marker. Taken together, data from 
this study clearly indicate a differential role of psychophysical versus social and 
of brief versus prolonged stress on neuroendocrine and immune function, 
suggesting that the quality and the extent of the stress period are crucial in 
determining individual neuroendocrine-immune responses to external 
challenges. 
 
5.1.3. Social deprivation and stressful events can amplify the consequences 
of a genetic susceptibility accelerating and precipitating breast 
cancer 
Initial and progressive stages of carcinogenesis are affected by both genetic and 
environmental factors: stressful events, in particular, might impair 
immunosurveillance or cause persistent inflammation during critical life phases, 
affecting tumor progression. More in detail, the central nervous system and the 
immune system are known to be engaged in an intense bidirectional crosstalk 
which can be affected by stress and which involves multiple mediators (Hayley 
et al., 2005; Cirulli and Alleva, 2009; Moreno-Smith et al., 2011; Capoccia et 
al., 2013). Epidemiological studies indicate that a dysregulation of the HPA axis 
has been linked to breast cancer mortality, predicted by disrupted cortisol 
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diurnal rhythms in women with metastatic disease (Sephton et al., 2000). 
Interestingly, recent findings link high levels of primary tumor glucocorticoid 
receptor expression (and associated increased glucocorticoid-mediated gene 
expression) to more rapid estrogen-independent breast cancer progression. 
Furthermore, animal models of human breast cancer suggest that 
glucocorticoids inhibit tumor cell apoptosis (Volden and Conzen, 2013). In this 
context, loneliness and lack of social support, a known psychosocial stressor, 
has been associated with pain, fatigue, lethargy and higher inflammation among 
cancer patients (Gagliardi et al., 2009; Hughes et al., 2014), while in mouse 
models of cancer, exposure to social isolation alters tumor and spleen 
macrophage populations and potentiates tumor growth and metastasis (Hermes 
et al., 2009; Williams et al., 2009; Madden et al., 2013; Volden and Conzen, 
2013). In Chapter 4, we investigated the effects of prolonged social isolation 
and restraint stress on a transgenic mouse model of breast cancer. Results 
indicate that in MMTVNeuTg mice social isolation accelerates disease onset, 
earlier detection of lumps in the mammary glands and tumor development, 
being accompanied by significant histological modifications in the mammary 
fat pad. More in detail, the histological analysis of mammary glands indicated 
that isolated transgenic mice display small, multilocular adipocytes that are 
reminiscent of brown adipose tissue. This kind of fat is exclusively detected in 
the mouse early in mammary gland development, particularly during stages of 
ductal growth, and is associated with the synthesis and secretion of angiogenic 
and growth factors, resulting in markedly increased vascular density and, 
therefore, involved in cancer development (Jones et al., 2011; Cao et al., 2014). 
Our data are in line with the recent discover that a switch from white to brown 
fat is found in cancer-associated cachexia and is linked to greater tissue energy 
expenditure (Petruzzelli et al., 2014). The higher presence of BAT in stressed 
and isolated mice indicates that these subjects have a more metabolically active 
tissue, a process that is likely to fuel the tumor, and which could favour the 
greater detection of breast lumps through palpation. It must be emphasized that, 
given the peculiarity of the transgenic model, it is likely that a ceiling effect at 
some point occurs so that it is hard to detect significant differences in tumor 
number. Nonetheless, a more metabolically active tissue could lead to an earlier 
onset of cachexia in these animals, a hypothesis that will need to be tested with 
subsequent studies (Petruzzelli et al., 2014). 
Cao and colleagues have suggested a neurophysiologic mechanism 
through which increased expression of hypothalamic BDNF, resulting from 
environmental enrichment, activates sympathetic innervation of white adipose 
tissue, leading to important changes in circulating levels of adipokines, 
ultimately resulting in tumor suppression (Cao and During, 2012). By studying 
this mechanism in an opposite situation, that is social isolation, we were able to 
show how stress experiences might promote cancer progression in 
MMTVNeuTg transgenic mice (see Chapter 4). We found that subjects 
experiencing both isolation and restraint stress were characterised by low BDNF 
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expression in the hypothalamus as well as increased leptin and decreased 
adiponectin expression in peripheral fat tissue, suggesting the involvement of a 
neuroendocrine/metabolic cascade in tumor progression. Leptin exerts pro-
angiogenic, pro-inflammatory, mitotic and anti-apoptotic actions inducing 
breast cancer development (Grossmann and Cleary, 2012; Khan et al., 2013). 
By contrast, adiponectin represses tumor proliferation in breast cancer cells, low 
blood concentrations of adiponectin being associated with high incidence and 
poor prognosis of breast cancer (Jarde et al., 2011). Interestingly, adipokines 
have been linked also to inflammation and we found that TNF-α decreased in 
isolated MMTVNeuTg mice after stressful challenge exposure, while IL-6 
production increased. These results are in line with the antitumor properties of 
TNF-α, which is a multifunctional cytokine, playing a key role in apoptosis and 
cell survival as well as in inflammation and immunity (van Horssen et al., 
2006). Indeed, our data reveal that chronic social isolation affects the 
production of this cytokine, promoting disease. As for IL-6, there is some 
evidence that elevated serum levels of this cytokine are important indicators of 
poor prognosis and can favor tumor growth (Nakashima et al., 2000; Petruzzelli 
et al., 2014). Complementing these data is the greater splenocyte apoptosis in 
MMTVNeuTg mice, an effect amplified by both stress procedures. 
It must be taken into account that the tumor can produce cytokines and 
humoral factors that act on the brain to cause sickness behaviour. The decreased 
preference for sweet solutions represents a properly feature of depression 
(Dantzer et al., 2008; Lamkin et al., 2011) and in the Chapter 4 we analyzed 
also this aspect finding increased expression of anhedonia in MMTVNeuTg 
mice both in the familiarization phase and during the restraint stress exposure, 
suggesting the potential role of a stressful challenge to precipitate depression 
symptoms.  
 
5.1.4. BDNF is a key molecule capable to integrate behavioural, immune 
and endocrine responses to stress  
The brain may be the missing link among emotions, stress, and disease. Results 
from this work show that the levels of the neurotrophin BDNF change 
according to behavioural phenotype (Chapters 2 and 4), neuroendocrine and 
immune responses (Chapters 3 and 4) and metabolic changes that can 
ultimately affect cancer progression (Chapter 4).  
BDNF is produced by different cell types including immune cells, 
adipocytes, endocrine and endothelial cells and has a key position in integrating 
neural, immune and endocrine responses to stressors (Chapter 3). This 
neurotrophin is involved in the neuronal plasticity of brain structures underlying 
mood circuitry and we found that chronic stress decreases its levels in the 
limbic regions such as the frontal cortex, hippocampus, midbrain and 
hypothalamus (Chapters 2, 3 and 4) promoting depression like-behaviour. The 
hypothalamus, in particular, was the brain region showing the greater difference 
 113 
in BDNF levels between socially isolated and group-housed mice. This piece of 
data is in agreement with previous reports suggesting a specific role of 
hypothalamic BDNF in regulating neuroendocrine responses to stress (Tapia-
Arancibia et al., 2004). As for the midbrain, this area is central to antidepressant 
action as is characterised by high levels of serotonin, a neurotransmitter 
involved in mood disorders, which is directly related to BDNF function 
(Thoenen et al., 1991; Lindholm et al., 1994). This neurotrophin, because of its 
well recognized role in depression, could be a crucial factor involved both in the 
potentiation of neuroendocrine responses to stress, and in mood modifications 
which accompany exposure to stress. In the case of cancer, it must be taken into 
account that a diagnosis of cancer and its treatments are stressful events. 
Emotional distress and negative affect states are common after a cancer 
diagnosis and treatment and contribute to increased anxiety, depressed mood, 
social disruption and sleep and fatigue-associated disruption (Ganz et al., 2002; 
Stanton, 2006; Antoni, 2013) which could precipitate disease progression and 
promote recurrence. It is important to consider that the tumor itself can produce 
depressive symptoms, which might generate a positive feedback loop between 
coping style and cancer progression (Sephton et al., 2009). In this regard, 
BDNF may also play a role. 
In Chapters 3 and 4 we found that, following stress exposure, specific 
changes in central levels of BDNF were associated to the profile of cytokines 
production and to anhedonia (Chapter 4). Interestingly, inflammation can also 
linked to peripheral adipokines production and in Chapter 4 low levels of 
hypothalamic BDNF were associated with increased leptin and decreased 
adiponectin gene expression in isolated transgenic mice. These results are in 
line with the recent description of BDNF as playing a main role in breast cancer 
cell growth, given its involvement in integrating neuroendocrine and metabolic 
responses to external challenges (Yang et al., 2012).  
In summary, BDNF appears involved in most physiological changes that 
accompany stress perception and response: HPA axis activation (Chapters 2, 3 
and 4), immune system function (Chapters 3 and 4), adipose metabolism 
(Chapter 4) and behavioural responses (Chapter 2 and 4) all regulating 
disease susceptibility. Thus, overall, our studies suggest that BDNF plays a 
central role in the orchestration of the brain and peripheral plasticity 
representing one of the principal mediators of this integrated response 
mechanism.  
 
 
5.2. IMPACT AND PERSPECTIVES 
The potentially negative impact of stressful life events on health and wellbeing 
is increasingly recognised as a significant public health issue. Indeed, 
decrements in health status and quality of life have been attributed to social 
factors such as poverty, early life adverse experiences, the presence or absence 
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of social support, employment status, the availability of food sources and the 
characteristics of the working environment (Marmot, 2005). Other studies have 
suggested that witnessing or experiencing violence, particularly intimate partner 
violence (Hegarty et al., 2004), political violence (Mollica et al., 1987; 
Eisenman et al., 2003) and child maltreatment (Felitti et al., 1998; Hegarty et 
al., 2004), may increase one’s risk of developing depressive symptoms. Others 
have linked stressful events such as war and conflict, natural disasters, academic 
failure, injury, job loss, major financial crises, divorce, illness or death of a 
loved one to the experience of poor health (Schwarzer R. and Schulz U., 2002; 
Humphreys and Lee, 2009; Humphreys et al., 2012).  
In summary, our data indicate that prolonged social isolation leads to 
long-term changes in HPA axis reactivity, in addition to reduced immune 
response and increased anxiety and depression like-behaviour in mouse models. 
It is of special interest that women are more at risk than men for depression and 
for most anxiety disorders. Studies in women specifically have suggested that 
social health issues and stressful life events are related to a range of physical 
and emotional health problems, and reduced health-related quality of life. These 
include increased sexual and reproductive health problems, chronic pain, 
somatic conditions, gastrointestinal disorders, suicidal ideation and risk-taking 
behaviours (Ellsberg et al., 2001). Interestingly, social isolation and related 
stress could contribute to increase susceptibility to disorders that are known to 
be characterised by a psychological component, such as human breast cancer 
(Gagliardi et al., 2009; Hughes et al., 2014). 
 
5.2.1. Delivering biomarkers for early detection and prevention strategies 
for breast cancer 
Breast cancer is the most common type of cancer in women throughout the 
world and remains a major health problem. The overall pattern of mortality for 
this cancer reveals high rates for Western, industrialized nations, particularly 
those of Northern Europe and North America, and lower rates for less 
industrialized and Asian nations. These differences in risk have been attributed 
to aspects thought to be profoundly involved in the aetiology of the disease such 
as dietary, cultural, and/or environmental factors. The risk of developing breast 
cancer is related to a number of factors including the events of reproductive life 
and lifestyle factors that modify endogenous levels of sex hormones.  
In Italy approximately 48,000 new cases of breast cancer have been 
diagnosed in 2013 and early diagnosis and care allows save many women each 
year (AIRTUM, 2013). According to the National Health Plan, a major attention 
should be placed on interventions targeted to implement healthy life styles. 
While diet and exercise have been also found to play an important role in the 
aetiology of breast cancer, there are other important factors that should be 
considered as they might act as an incentive for inadequate life styles. 
Psychological stress, in particular, could favour bad eating habits or boost 
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cigarette smoking. Chronic levels of elevated cortisol characterising stress can 
weaken the ability of the immune system to fight disease, including not only 
breast cancer, but also high blood pressure, elevated blood glucose (linked with 
increased risk of weight gain and diabetes), and osteoarthritis. In addition, 
stressful life events could lead to a depressed state and influence cancer 
progression through alterations of immune functioning. Thus co-morbidity 
exists between stress-derived pathologies that might interact, leading to an 
amplification of effects with consequences on tumor progression or on recurring 
illness. 
Data obtained from animal models might help identifying validated 
peripheral markers of stress and immune function related to breast cancer 
progression to allow rapid translation to the clinic and to study prospectively 
prognostic factors for development of depressive status of patients during 
chemotherapy. In particular, BDNF and pro-inflammatory cytokines stimulate 
multiple intracellular signalling cascades involved in the disruption of 
emotional state and in mood modifications known to characterise cancer 
patients. In this context, the increased levels of IL-6 and the decreased 
expression of BDNF could represent valid biomarkers for early detection of 
individuals more susceptibile to the negative consequences of stress. 
In addition, targeting the neuroendocrine effector pathways in tumor cells 
(e.g. the use of GR antagonists and GR selective modulators) may benefit those 
cancer patients with a tumor microenvironment that could render them 
particularly susceptible to GC signalling effects. Therefore, to optimize patient 
care, cancer and behavioural researchers will must work together to understand 
the influence of glucocorticoid signalling in human cancer biology (Volden and 
Conzen, 2013).  
Psychosocial interventions teach stress management skills (relaxation and 
coping strategies) to decrease distress and interpersonal skills to build social 
support (Antoni, 2013), improving the quality of life and helping to manage 
pain and other physical symptoms. In this context cognitive behavioural therapy 
could reduce tension, anxiety and distress through relaxation training, 
mindfulness, hypnosis, yoga and other techniques (Spiegel, 2008). Indeed, the 
professional figure of psycho-oncologist could be relevant to help patients 
during the management of disease and to identify frailty individuals most 
susceptible to adverse psychological outcomes and at high risk for relapse.  
It must be taken into account that recent studies have shown that 
moderate physical activity can be beneficial for the brain and metabolic systems 
(Perseghin et al., 1996; Kramer et al., 2003; Barbour and Blumenthal, 2005). 
Voluntary physical activity has been shown to increase neurotrophin expression 
in cortex and hippocampal regions of the brain (Cotman and Berchtold, 2002), 
as well as to increase neurogenesis in the dentate gyrus in animals (van Praag et 
al., 2005). Moreover, increased neurogenesis in dentate gyrus has been linked to 
the actions of antidepressant drugs, providing a potential parallel with the 
antidepressant actions of physical activity (Olson et al., 2006). Increased 
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neurogenesis improves memory (Wiskott et al., 2006) and may contribute to 
greater cognitive flexibility (Karten et al., 2006; Wiskott et al., 2006). Since 
loneliness appears enhance cancer-related fatigue and physical disfunction, 
cognitive problems, anxiety and depression (Antoni, 2013; Mustian et al., 
2013), the promotion of social groups dedicated to physical activity among 
cancer patients, could represent a valid therapeutic instrument. Importantly, 
cumulative evidence from social epidemiological studies has repeatedly 
demonstrated that different dimensions of social relationships can affect 
longevity and health via unique neurobehavioural pathways (Cohen, 2004; 
Cohen and Janicki-Deverts, 2009). One dimension of social relationships that 
has been most consistently linked to longevity and health is social integration, a 
multidimensional construct referring to an individual's effortful behavioural 
engagement in wide ranging social activities and relationships. 
It must be taken into account that not only exercise, but also diet can play 
an important role in the aetiology of breast cancer. Psychological stress could 
favour bad eating habits leading to a shift to dysfunctional adipose tissue. In 
addition to its lipid-storing capacity, fat is a highly active endocrine and 
metabolic organ. Adipose tissue, which is made up of various cell types, such as 
adipocytes, pre-adipocytes, fibroblasts, macrophages, and blood vessels, 
produces numerous adipokines, such as leptin and adiponectin, that can 
stimulate or inhibit cell growth (van Kruijsdijk et al., 2009). In Chapter 4, we 
found that a mouse model of breast cancer, experiencing both isolation and 
restraint stress, was characterised by increased leptin and decreased adiponectin 
gene expression in peripheral adipose tissue, both promoting tumor progression.  
 Data from animal study could help to deliver biomarkers that can be used 
for early screening and prevention strategies: intervening early in the disease 
course could help the identification of patients with high risk of recurrence and 
ameliorate quality of life.  
 
 
5.3. CONCLUSIONS 
There is increasing evidence that stressful events can compromise the 
physiological response as well as behavioural strategies, promoting mood 
disorders and precipitating disease. The work presented in this thesis underlies 
the importance of considering the quality and timing of stressors in determining 
individual neuroendocrine-immune responses to external challenges.  
While this is a first attempt to mimic some of the qualitative and temporal 
features of “stress,” our data clarify the mechanisms through which the length 
of stress can affect an organism, identifying a specific neuroendocrine-immune 
profile associated to specific changes in central mediators and behaviour. Stress 
affects peripheral targets acting through a mechanism that involves the HPA 
axis activity, cytokines production and metabolic response. In this context, the 
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neurotrophin BDNF appears the key molecule involved in all neurobiological 
changes that accompany stress appraisal. 
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